hg_122685.1

Basic information about the TSS

---

TSS ID: hg_122685.1 Species: human Chr: chr11		Start: 119057218 End: 119057229 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000652093.1 Distance: 0 GeneID: 10525 HGNC/MGI_ID: HGNC:16931 UniProt_ID: A0A494C039

Gene_name: hypoxia up-regulated 1 Gene_symbol: HYOU1 Gene_synonyms: Grp170 HSP12A ORP150 Gene_source: HGNC:16931

TATA-Box annotation

---

Distance to TSS:	-19
Nearest PromoterID:	NM_001130991
Entrez ID:	10525
Nearest Unigene:	Hs.277704
Nearest Refseq:	NM_006389
Nearest Ensembl:	ENSG00000149428
Gene Name:	hypoxia up-regulated 1
Gene Alias:	GRP-170|Grp170|HSP12A|IMD59|ORP-150|ORP150
Gene Description:	hypoxia up-regulated 1
Gene Type:	protein-coding
CpG%:	0.14
GC%:	0.736318
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@HYOU1 p2@HYOU1 p3@HYOU1 p4@HYOU1 p5@HYOU1 p6@HYOU1
Sample		p1@HYOU1	p2@HYOU1	p3@HYOU1	p4@HYOU1	p5@HYOU1	p6@HYOU1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	10.13	16.56	1.17	0.19	0.39	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	10.32	16.59	0.61	0.20	1.01	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	11.00	15.63	1.35	0.39	0.19	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	11.23	12.47	1.46	0.00	0.21	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	9.22	15.07	1.57	0.00	0.22	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	10.66	16.09	0.58	0.00	0.00	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	10.46	23.10	1.53	0.44	0.22	1.09
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	7.75	16.71	1.45	0.73	0.73	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	10.69	14.53	1.28	0.00	0.85	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	5.80	10.43	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	5.26	12.94	0.40	0.00	0.00	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	4.88	12.60	0.41	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	6.93	4.84	1.29	0.48	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	10.07	4.96	0.90	0.75	0.60	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	10.98	7.03	1.54	0.44	0.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	8.30	4.53	1.51	1.76	1.01	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	6.33	3.93	0.44	0.22	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	9.28	2.11	0.00	0.00	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	7.46	4.27	1.07	2.13	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	7.67	5.12	0.75	0.90	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	8.82	4.41	1.47	0.94	1.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	10.01	5.01	0.35	1.21	0.86	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	7.76	5.30	1.16	0.90	0.26	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	9.22	3.64	1.21	0.73	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	8.26	4.90	0.00	0.26	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	7.60	5.70	1.90	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	4.95	6.59	0.55	0.55	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	8.25	4.72	0.94	2.12	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	5.98	4.20	1.62	0.97	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	7.42	6.15	0.90	1.27	0.18	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	3.77	5.02	1.26	0.63	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	6.45	4.88	0.98	1.76	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	5.91	4.64	0.63	0.42	1.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	6.93	5.44	1.32	0.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	6.54	3.74	0.56	0.93	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	7.09	4.60	0.96	0.77	0.57	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	7.97	5.93	0.20	1.23	0.41	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	5.84	4.43	0.81	1.21	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	8.64	4.86	1.08	1.08	0.81	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	5.28	5.04	0.72	1.20	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	8.23	5.65	0.71	0.71	0.24	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	9.08	4.54	0.59	0.59	0.15	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	8.44	4.01	0.63	1.05	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	6.47	5.24	1.40	1.22	0.52	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	10.44	6.42	1.61	1.20	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	11.86	6.51	2.56	0.70	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	7.44	5.04	0.96	0.96	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	15.80	7.75	1.49	0.89	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	22.26	7.18	2.39	0.24	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	20.02	6.87	2.02	1.01	0.81	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	25.21	12.30	2.87	1.43	0.41	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	26.24	11.56	1.78	1.33	0.89	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	363.80	69.96	27.98	0.00	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	17.39	7.10	3.55	0.71	1.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	33.14	10.27	3.98	1.99	0.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	105.71	20.97	2.52	1.68	1.68	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	53.73	13.78	6.43	0.46	1.38	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	37.60	9.08	2.59	0.97	1.30	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	24.41	9.31	4.82	2.57	0.64	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	68.21	18.55	5.66	1.26	1.57	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	29.61	7.76	2.12	1.41	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	33.65	12.90	4.49	2.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	121.01	35.03	14.33	2.39	3.18	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	45.87	23.44	4.08	1.70	1.02	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	23.72	14.30	4.55	0.65	0.65	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	24.14	12.07	2.48	1.42	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	290.95	32.33	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	252.72	39.49	7.90	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	20.96	11.21	1.95	0.49	1.46	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	20.83	20.83	4.46	2.48	1.49	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	28.15	15.01	3.28	1.88	1.41	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	33.45	14.24	4.31	2.32	1.66	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	17.63	11.75	4.02	1.24	0.00	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	27.82	13.15	3.67	1.22	1.53	0.00
Adipocyte - breast, donor1	11376-118A8	34.53	13.46	1.43	1.74	1.11	0.32
Adipocyte - breast, donor2	11327-117E4	22.94	8.66	2.09	3.37	0.32	0.48
Adipocyte - omental, donor1	11473-119C6	51.02	15.78	2.29	2.54	1.40	1.40
Adipocyte - omental, donor2	11474-119C7	22.42	9.72	2.99	3.74	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	25.45	9.04	1.67	4.35	0.00	0.67
Adipocyte - perirenal, donor1	11476-119C9	25.52	17.86	1.28	4.47	0.64	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	13.19	2.20	0.00	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	47.42	6.32	1.81	1.35	1.35	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	7.99	5.04	1.39	1.22	0.70	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	51.63	26.79	3.52	3.13	1.96	1.56
Adipocyte differentiation, day04, donor2	13022-139D7	37.06	9.52	3.86	2.83	0.77	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	49.06	14.50	5.02	3.07	0.84	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	40.56	10.58	2.94	1.18	1.18	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	23.57	12.06	1.13	1.53	0.80	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	29.69	9.36	0.97	1.61	0.97	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	22.93	9.60	0.53	2.13	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	17.81	5.56	1.11	0.00	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	17.47	9.57	1.25	1.66	1.25	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	19.59	5.53	2.26	1.26	0.25	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	20.62	4.58	0.98	2.29	0.33	0.98
Adipocyte differentiation, day12, donor4	13030-139E6	10.05	2.13	0.61	0.61	1.22	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	41.77	32.04	3.31	2.65	1.55	0.88
Alveolar Epithelial Cells, donor2	11590-120G6	9.32	9.68	1.08	0.36	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	29.95	14.38	3.59	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	30.76	22.49	7.02	3.24	0.36	0.90
Amniotic Epithelial Cells, donor2	11613-122A2	16.73	13.39	3.35	0.00	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	20.34	16.85	4.52	1.64	1.44	0.21
Anulus Pulposus Cell, donor1	11248-116E6	5.84	3.32	0.92	1.95	0.11	0.23
Anulus Pulposus Cell, donor2	11463-119B5	5.88	2.94	1.22	1.71	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	18.87	4.04	1.35	1.35	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	19.10	7.81	0.43	1.74	0.00	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	29.96	4.28	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	18.53	8.37	1.79	1.20	0.00	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	25.29	6.32	2.53	5.06	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	14.52	5.28	1.32	0.00	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	19.17	5.52	1.95	0.65	0.00	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	16.99	8.25	1.46	1.46	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	17.22	5.34	0.59	1.19	0.00	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	22.97	8.29	1.13	1.88	1.13	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	23.95	2.90	1.45	1.45	1.45	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	17.55	5.02	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	23.72	8.40	1.32	2.80	0.66	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	25.93	2.73	2.73	2.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	15.23	4.52	0.60	1.51	0.30	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	19.29	6.97	1.07	1.07	0.54	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	19.27	6.23	0.38	2.65	0.76	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	17.64	5.61	2.14	2.14	0.27	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	11.71	6.83	0.00	0.98	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	13.93	5.31	0.83	1.99	0.17	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	9.61	3.60	0.00	1.20	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	24.78	0.00	0.00	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	20.07	6.18	1.89	1.89	0.51	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	16.02	3.88	0.49	2.91	0.49	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	16.70	9.87	0.76	3.04	0.00	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	14.54	1.21	1.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	19.95	5.13	0.57	2.28	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	18.81	6.20	1.50	2.57	0.21	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	13.16	5.42	0.77	1.81	1.29	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	15.95	4.22	0.47	0.47	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	18.97	4.82	0.96	1.61	0.64	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	15.70	8.56	2.85	2.14	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	13.45	2.92	0.58	0.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	18.37	9.33	1.20	1.51	0.30	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	15.44	5.94	0.00	3.56	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	19.83	5.09	3.56	2.03	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	22.67	8.15	2.55	2.04	0.25	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	12.07	6.35	0.64	1.91	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	15.97	8.63	0.86	0.86	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	15.88	5.93	1.91	1.27	0.00	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	11.89	4.35	0.00	1.16	0.00	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	18.89	6.61	1.89	1.89	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	15.77	7.97	0.51	1.53	0.51	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	11.58	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	21.13	8.45	2.11	4.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	18.87	8.36	1.72	1.93	0.64	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	12.63	4.21	1.20	1.20	0.00	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	14.58	2.19	3.64	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	18.16	7.59	1.15	2.30	0.23	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	22.95	5.10	0.00	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	11.19	5.59	0.51	1.53	1.02	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	17.75	7.64	1.86	2.68	0.62	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	13.16	8.57	0.31	0.61	0.00	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	21.99	2.87	0.48	2.87	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	20.84	10.42	1.11	3.55	0.89	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	13.73	4.58	0.00	3.05	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	16.62	4.98	1.11	1.11	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	20.12	9.00	1.06	1.06	0.53	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	13.08	5.09	0.36	1.09	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	34.02	26.90	5.90	2.95	0.86	0.25
Astrocyte - cerebellum, donor2	11580-120F5	23.28	16.26	3.59	4.79	2.05	1.03
Astrocyte - cerebellum, donor3	11661-122F5	26.01	14.47	2.94	2.10	1.26	1.05
Astrocyte - cerebral cortex, donor1	11235-116D2	25.45	20.92	2.79	3.83	0.70	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	29.12	20.55	0.65	0.97	1.94	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	34.75	25.80	3.28	2.98	2.24	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	18.92	14.45	1.72	1.38	2.29	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	28.19	13.78	2.26	1.38	1.75	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	26.06	11.49	1.71	1.93	1.14	0.11
Basophils, donor1	12241-129G9	20.92	8.11	3.40	1.57	0.26	0.26
Basophils, donor2	12242-129H1	41.49	10.10	3.25	1.80	0.00	0.72
Basophils, donor3	12243-129H2	22.34	6.61	1.62	1.32	0.88	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	16.82	5.61	1.94	0.86	1.08	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	10.52	9.14	1.83	0.46	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	11.93	5.02	0.63	0.63	0.00	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	25.16	15.80	1.87	3.33	0.83	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	26.25	22.80	4.15	1.15	0.23	1.15
Bronchial Epithelial Cell, donor7	11769-123I5	15.84	3.42	1.80	1.98	1.26	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	27.31	12.26	1.75	1.44	1.13	0.93
Burkitt's lymphoma cell line:RAJI	10476-106I8	61.95	23.52	3.03	0.23	0.70	1.63
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	39.01	15.35	0.96	0.64	0.64	2.24
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	19.16	4.51	1.13	1.69	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	12.44	2.41	0.37	1.30	0.74	0.19
CD14+ Monocytes, donor3	11381-118B4	11.64	2.20	0.22	0.00	0.44	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	15.00	5.38	1.42	2.26	1.42	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	15.92	9.10	0.38	3.03	2.27	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	9.86	3.62	1.64	0.99	1.97	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	8.82	2.02	0.58	0.58	0.00	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	12.97	2.11	0.30	0.30	0.30	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	11.61	1.90	0.00	0.71	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	10.21	1.84	0.17	0.67	0.50	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	13.80	4.14	0.83	1.10	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	14.88	3.47	0.74	0.25	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	8.42	1.17	0.59	0.59	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	11.22	3.74	0.71	0.53	0.71	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	14.80	3.92	0.65	0.87	0.22	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	7.49	1.40	0.00	0.70	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	14.78	2.64	0.00	1.06	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	11.09	5.55	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	9.37	1.93	0.00	0.30	0.00	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	14.37	3.59	0.60	1.00	0.00	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	19.99	4.37	0.62	0.42	0.42	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	9.84	2.06	0.00	0.92	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	16.51	4.30	0.23	0.00	0.45	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	13.53	1.75	0.87	0.44	0.00	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	6.72	2.42	0.00	1.08	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	11.86	3.31	0.35	0.17	0.35	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	9.68	1.26	1.26	0.00	1.68	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	10.66	1.84	0.00	0.92	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	9.86	3.87	1.41	1.06	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	13.16	4.39	0.44	0.44	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	8.72	2.09	0.35	0.35	0.35	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	14.12	4.46	1.12	1.49	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	14.87	4.53	1.51	1.29	0.22	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	9.01	2.46	0.41	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	14.60	3.25	0.93	0.93	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	15.08	3.94	0.70	0.93	0.00	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	10.90	5.01	1.74	0.87	0.44	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	10.63	4.62	0.69	0.00	0.46	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	10.83	4.55	0.87	0.65	0.43	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	14.64	4.52	1.56	1.71	0.31	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	8.91	2.62	1.05	0.70	0.70	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	17.84	8.03	1.78	0.22	0.67	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	4.59	3.57	0.77	0.26	0.77	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	5.49	3.07	0.66	1.10	0.44	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	6.95	5.05	1.05	0.21	0.63	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	20.32	10.16	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	10.17	8.81	0.68	2.03	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	12.43	4.14	4.14	2.07	2.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	27.72	6.93	1.60	0.53	0.53	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	14.47	6.43	0.54	0.54	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	19.65	6.32	1.40	0.00	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	16.47	3.14	0.78	0.00	0.78	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	14.50	9.23	2.64	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	4.93	6.58	1.64	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	7.98	3.63	0.73	0.73	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	8.58	1.51	0.00	0.50	0.50	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	22.63	20.20	3.23	0.81	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	20.37	17.18	1.60	1.60	0.40	0.40
CD34+ Progenitors, donor1	11545-120B6	12.05	8.03	0.00	1.00	2.01	0.00
CD34+ Progenitors, donor2	11625-122B5	40.45	4.49	0.56	0.00	0.00	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	45.47	10.15	2.63	1.50	1.13	1.88
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	46.22	12.85	2.03	1.13	1.13	1.58
CD4+ T Cells, donor1	11225-116C1	15.35	5.36	1.07	0.36	0.36	0.71
CD4+ T Cells, donor2	11306-117C1	26.33	4.90	1.22	0.61	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	21.04	8.54	1.52	0.91	0.61	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	21.70	7.66	2.55	1.53	0.26	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	19.32	8.31	2.02	2.47	0.67	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	12.36	8.34	2.01	2.59	1.44	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	14.70	3.79	0.95	0.95	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	10.53	4.21	3.51	0.70	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	9.89	3.30	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	30.78	12.14	3.32	1.73	0.58	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	18.47	7.80	2.54	1.36	0.85	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	18.54	7.90	2.90	2.58	0.97	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	10.76	5.38	2.24	0.90	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	11.88	4.54	0.70	1.40	0.00	1.05
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	13.64	6.60	0.88	0.88	0.44	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	18.13	9.70	2.95	2.11	1.69	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	19.32	6.86	2.29	1.04	0.62	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	18.04	11.69	1.34	0.67	0.33	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	13.87	6.53	1.90	0.00	1.36	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	11.79	8.58	1.07	1.07	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	8.97	3.59	0.00	1.79	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	26.70	10.57	4.26	1.67	0.56	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	26.64	11.26	3.03	1.73	1.08	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	25.01	13.66	4.83	1.89	1.26	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	22.25	3.54	2.53	0.00	1.01	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	18.20	5.63	0.87	0.87	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	27.89	16.56	2.61	0.00	0.00	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	19.79	7.42	2.47	1.48	3.96	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	14.77	6.46	2.77	2.77	2.77	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	13.96	13.96	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	19.94	12.46	3.88	3.60	1.38	0.83
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	21.35	14.72	5.40	2.21	0.98	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	23.10	15.40	0.00	0.00	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	22.20	9.31	0.72	2.15	1.07	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	18.00	12.46	1.38	1.38	5.54	0.00
CD8+ T Cells, donor1	11226-116C2	39.94	10.15	1.96	1.96	1.64	0.00
CD8+ T Cells, donor2	11307-117C2	23.65	4.88	1.88	1.13	1.50	0.00
CD8+ T Cells, donor3	11383-118B6	24.74	8.84	1.77	1.01	1.01	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	63.08	18.58	5.51	3.67	0.46	5.28
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	58.47	19.17	4.31	5.27	0.72	3.59
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	64.57	16.96	4.38	1.64	0.55	3.28
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	52.24	15.31	4.80	2.70	0.00	3.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	43.92	13.92	4.08	5.28	0.48	2.88
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	46.16	19.78	2.50	4.09	0.23	1.82
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	62.36	18.69	3.69	5.43	0.65	2.82
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	55.01	18.42	5.53	4.21	0.00	3.68
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	68.95	22.75	3.28	3.75	0.23	3.05
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	86.04	18.11	6.34	7.25	1.21	4.53
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	80.47	13.94	4.65	4.36	0.00	3.78
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	79.13	19.98	6.39	4.53	0.80	2.66
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	24.51	10.94	5.25	1.75	0.00	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	31.88	12.30	2.73	0.46	0.00	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	23.87	12.68	1.49	0.75	0.00	2.24
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	39.62	16.21	2.88	3.96	1.08	2.16
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	35.39	18.70	4.32	3.45	0.00	2.88
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	38.65	15.56	2.59	4.24	0.47	2.36
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	65.92	19.65	5.70	5.70	0.63	2.85
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	57.21	14.46	4.61	4.00	1.23	3.08
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	53.22	18.27	5.13	5.77	0.64	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	68.46	14.92	3.82	1.53	0.00	2.29
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	57.54	13.79	5.91	3.55	2.36	2.36
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	49.17	16.64	6.05	2.27	1.51	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	35.33	21.68	3.21	1.61	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	40.57	21.68	2.10	2.10	0.70	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	36.06	24.04	4.01	3.01	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	7.31	7.31	1.83	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	27.67	12.35	3.95	2.47	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	34.94	11.79	2.74	1.79	1.26	0.63
Chondrocyte - de diff, donor1	11261-116G1	16.29	10.40	1.39	0.69	0.69	1.73
Chondrocyte - de diff, donor2	11338-117F6	15.99	7.82	1.07	1.42	0.71	1.07
Chondrocyte - de diff, donor3	11410-118E6	12.06	3.75	0.34	0.91	0.34	0.34
Chondrocyte - re diff, donor2	11339-117F7	34.02	18.80	2.69	4.48	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	19.41	12.54	3.24	2.02	1.62	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	28.69	16.30	3.33	1.15	2.30	0.57
Ciliary Epithelial Cells, donor2	11323-117D9	33.35	16.03	1.92	2.57	1.50	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	25.40	16.99	1.59	2.21	2.04	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	26.41	17.51	2.93	10.36	2.84	0.46
Corneal Epithelial Cells, donor1	11526-119I5	29.20	13.83	3.51	1.54	1.10	0.66
Corneal Epithelial Cells, donor2	11606-120I4	5.69	9.10	1.14	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	17.89	12.01	2.05	0.26	1.53	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	14.69	8.58	1.98	2.81	0.50	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	18.29	9.46	0.63	1.89	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	10.35	0.00	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	11.66	6.48	1.51	1.84	0.97	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	113.77	48.85	6.15	3.76	2.39	1.71
Dendritic Cells - plasmacytoid, donor2	11309-117C4	113.60	41.78	1.96	3.26	3.92	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	118.57	46.94	7.74	0.97	0.97	2.90
Endothelial Cells - Aortic, donor0	11207-116A1	41.53	19.85	3.17	2.33	0.83	0.67
Endothelial Cells - Aortic, donor1	11263-116G3	24.06	12.91	1.17	1.76	0.59	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	47.23	14.14	5.37	1.98	0.28	1.13
Endothelial Cells - Aortic, donor3	11412-118E8	31.45	21.63	1.57	3.15	1.18	1.18
Endothelial Cells - Artery, donor1	11264-116G4	32.58	13.09	0.87	2.91	0.29	0.29
Endothelial Cells - Artery, donor2	11341-117F9	40.23	14.82	2.82	2.35	0.00	0.94
Endothelial Cells - Artery, donor3	11413-118E9	34.01	19.81	1.93	2.28	0.35	0.70
Endothelial Cells - Lymphatic, donor1	11236-116D3	18.62	7.31	1.33	0.66	0.66	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	21.91	12.78	1.83	0.91	1.22	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	27.91	14.38	1.13	1.41	0.85	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	25.26	13.37	1.78	1.78	1.49	0.89
Endothelial Cells - Microvascular, donor2	11342-117G1	20.31	8.85	1.04	1.04	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	11.63	5.96	1.56	1.13	0.85	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	32.81	23.61	2.40	2.40	0.40	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	37.74	11.53	2.62	2.62	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	40.38	23.73	3.11	2.61	1.49	0.99
Endothelial Cells - Umbilical vein, donor2	11324-117E1	20.86	16.95	1.52	2.17	1.52	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	28.09	17.10	3.42	2.44	2.20	0.24
Endothelial Cells - Vein, donor1	11267-116G7	37.54	6.83	2.28	1.14	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	26.54	8.38	2.79	2.10	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	38.15	18.68	2.20	3.30	1.10	1.26
Eosinophils, donor1	12244-129H3	45.74	15.25	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	13.20	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	28.53	10.70	0.00	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	26.88	11.97	3.66	2.93	0.98	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	6.24	4.16	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	25.45	8.21	1.64	0.41	0.00	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	8.65	4.38	0.55	0.99	0.00	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	2.06	1.19	0.00	0.76	0.11	0.43
Fibroblast - Aortic Adventitial, donor1	11245-116E3	39.42	12.13	2.67	2.30	0.73	1.21
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	44.35	17.74	2.18	1.77	0.27	1.23
Fibroblast - Aortic Adventitial, donor2	11326-117E3	17.09	7.80	1.48	1.37	0.42	1.05
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	108.29	29.77	10.01	1.84	0.26	8.17
Fibroblast - Aortic Adventitial, donor3	11401-118D6	27.90	9.97	1.99	2.99	1.33	1.00
Fibroblast - Cardiac, donor1	11268-116G8	24.95	11.79	1.81	4.08	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	41.69	24.25	2.27	0.76	0.00	1.52
Fibroblast - Cardiac, donor3	11417-118F4	33.75	13.25	1.10	1.89	0.63	1.42
Fibroblast - Cardiac, donor4	11452-119A3	24.85	10.91	0.30	4.24	0.91	0.30
Fibroblast - Cardiac, donor5	11456-119A7	31.47	16.88	2.66	2.66	0.51	1.78
Fibroblast - Cardiac, donor6	11460-119B2	26.07	15.46	1.82	2.88	0.76	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	34.17	20.77	6.03	5.36	0.67	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	23.73	9.92	0.43	3.45	1.29	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	45.41	27.83	4.39	1.46	1.46	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	37.13	18.45	2.31	3.00	1.38	2.31
Fibroblast - Conjunctival, donor3	11692-122I9	7.80	3.90	0.17	2.04	0.51	0.17
Fibroblast - Dermal, donor1	11269-116G9	6.57	2.58	0.47	0.70	0.47	0.23
Fibroblast - Dermal, donor2	11346-117G5	18.40	4.72	0.94	1.42	0.47	0.47
Fibroblast - Dermal, donor3	11418-118F5	5.68	3.14	0.73	0.85	0.48	0.12
Fibroblast - Dermal, donor4	11450-119A1	12.66	10.85	2.03	1.92	0.23	0.34
Fibroblast - Dermal, donor5	11454-119A5	17.45	13.96	1.05	2.09	0.70	0.17
Fibroblast - Dermal, donor6	11458-119A9	18.68	11.69	1.30	2.11	0.49	0.49
Fibroblast - Gingival, donor1	11237-116D4	10.00	4.79	1.04	2.29	0.42	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	16.51	5.50	1.31	1.05	0.52	0.79
Fibroblast - Gingival, donor2	11318-117D4	15.81	10.54	1.45	1.45	0.40	0.26
Fibroblast - Gingival, donor3	11394-118C8	9.77	6.28	0.29	1.55	0.19	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	24.93	5.19	1.04	1.04	1.04	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	15.86	5.81	0.35	0.88	0.18	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	22.60	14.03	1.71	2.34	1.25	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	16.23	7.71	0.95	2.57	0.41	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	7.76	3.88	0.71	1.06	1.06	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	17.99	7.60	0.73	1.75	1.32	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	18.68	11.59	0.82	1.91	0.68	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	40.48	20.51	2.19	2.19	0.88	0.77
Fibroblast - Gingival, donor9 (control)	11927-125I1	13.50	4.99	1.47	1.61	0.59	0.44
Fibroblast - Lung, donor1	11270-116H1	19.03	0.00	0.00	4.08	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	10.45	4.48	0.00	1.49	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	10.97	4.64	0.84	2.74	0.63	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	35.82	19.99	4.17	6.66	1.67	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	8.39	8.39	1.40	4.20	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	9.80	3.36	0.84	2.24	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	35.32	21.92	5.28	2.03	0.00	0.41
Fibroblast - Mammary, donor2	11620-122A9	3.99	11.98	0.00	3.99	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	0.00	0.00	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	20.95	11.64	1.16	0.78	0.78	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	12.44	11.38	1.67	1.21	1.06	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	12.85	14.38	1.53	0.92	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	17.55	10.69	2.29	1.91	0.38	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	25.92	5.94	1.35	2.43	0.81	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	17.86	8.81	1.04	1.39	0.70	0.70
Fibroblast - Pulmonary Artery, donor1	11250-116E8	43.88	19.01	1.66	2.43	0.55	0.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	46.53	32.51	5.08	4.06	0.61	1.02
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	21.38	10.02	1.34	2.67	2.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	11.07	3.56	0.79	3.16	0.79	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	57.75	26.79	4.56	1.59	0.20	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	10.66	5.15	0.89	0.18	0.36	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	19.12	5.52	0.59	0.79	0.20	0.99
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	56.26	24.37	5.42	2.41	0.60	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	13.39	8.20	1.51	1.62	0.54	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	26.32	12.40	3.54	1.52	0.00	1.01
Fibroblast - skin normal, donor1	11553-120C5	10.83	7.06	1.80	1.31	0.66	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	75.39	41.50	5.21	2.81	1.80	2.01
Fibroblast - skin normal, donor2	11561-120D4	22.20	11.85	2.11	1.81	0.10	1.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	25.69	16.02	3.93	2.72	0.60	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	16.32	7.21	0.91	0.91	0.25	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	8.21	5.64	1.37	1.20	0.85	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	39.41	14.45	5.58	1.31	1.31	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	23.43	13.95	2.24	2.45	0.43	0.53
Fibroblast - skin walker warburg, donor1	11554-120C6	24.12	13.49	1.69	1.86	1.52	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	18.98	6.12	1.88	1.10	0.31	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	0.00	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	10.46	6.97	1.74	0.87	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	26.00	13.52	2.08	0.69	0.52	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	62.46	26.02	2.60	1.82	1.04	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	36.79	31.17	1.79	1.79	2.04	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	26.03	8.42	1.53	0.00	2.30	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	26.16	27.44	1.91	1.91	0.64	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	36.23	41.36	4.28	0.29	3.42	2.85
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	15.72	27.02	1.93	2.76	2.76	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	12.10	19.64	2.05	2.28	1.60	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	21.99	29.13	2.58	0.99	2.18	1.19
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	17.45	28.81	2.91	2.11	1.85	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	10.11	18.59	0.98	1.96	1.63	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	22.55	39.36	4.42	0.88	3.10	2.21
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	19.36	26.43	3.82	0.99	2.12	0.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	22.29	23.89	4.06	0.86	2.09	0.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	19.34	16.65	2.42	0.27	2.42	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	23.42	19.70	2.73	0.87	1.24	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	19.79	21.18	3.18	0.28	1.52	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	15.45	16.67	1.63	0.61	0.81	1.02
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	22.13	15.52	1.60	0.23	0.46	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	16.82	13.45	2.74	0.87	1.25	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	18.80	14.86	3.72	0.44	1.75	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	20.68	13.89	2.36	0.59	1.48	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	21.30	15.26	2.38	1.43	0.48	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	23.24	14.52	3.13	0.45	1.79	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	17.95	14.32	2.62	0.81	1.01	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	21.88	14.25	4.58	1.53	1.02	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	37.86	24.47	3.19	1.15	1.42	0.98
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	19.35	18.11	2.91	1.14	1.66	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	18.10	18.44	3.24	0.51	0.51	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	16.82	15.05	2.55	0.55	1.33	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	31.78	20.05	3.33	1.08	1.75	0.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	24.91	21.03	3.06	1.02	1.43	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	13.82	9.49	2.68	0.62	1.24	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	17.29	16.26	2.08	0.46	0.81	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	21.18	13.51	2.50	0.83	0.83	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	14.11	10.14	1.54	0.22	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	17.22	13.41	2.71	0.98	0.25	0.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	23.67	13.13	2.92	0.81	1.30	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	17.32	11.23	2.25	1.28	0.64	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	14.50	11.65	1.71	0.66	0.38	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	13.76	6.80	2.06	0.95	1.11	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	16.12	9.73	1.82	0.61	1.52	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	18.82	13.49	2.72	0.94	0.84	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	12.30	8.56	3.29	0.66	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	15.71	7.86	2.81	1.12	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	21.48	11.85	2.22	1.30	0.74	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	17.65	10.96	1.60	0.53	0.53	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	18.82	11.48	0.61	0.46	0.61	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	22.54	12.05	1.42	1.55	0.52	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	23.04	9.49	2.44	1.90	1.36	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	20.65	7.74	1.84	0.55	1.11	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	17.98	9.21	0.66	1.54	0.66	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	17.85	2.98	1.98	0.99	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	24.67	10.03	1.06	1.98	0.53	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	19.97	9.28	2.62	0.81	0.40	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	17.28	13.22	1.78	1.52	1.27	1.27
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	26.67	55.14	8.76	0.80	2.39	0.80
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	20.80	32.51	6.16	0.15	2.16	1.08
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	29.26	41.53	6.96	0.61	4.30	1.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	29.10	25.66	3.13	0.94	1.88	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	24.02	19.78	2.54	0.57	1.41	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	19.37	20.29	3.23	0.92	2.31	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	24.75	9.90	7.42	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	31.33	23.21	0.77	1.16	1.16	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	28.88	28.88	1.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	31.30	26.08	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	28.97	16.60	3.25	1.30	0.33	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	32.94	18.12	5.77	1.24	1.24	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	23.33	29.99	0.00	3.33	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	30.48	11.19	3.64	1.68	1.40	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	30.07	17.65	2.29	0.33	0.98	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	36.91	18.45	1.68	0.00	1.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	32.44	14.31	2.23	1.27	0.64	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	24.80	13.59	3.40	0.34	0.00	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	18.79	8.35	0.00	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	22.34	16.61	1.72	1.72	2.29	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	20.42	11.84	2.37	0.89	1.18	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	22.02	15.25	1.69	1.69	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	36.86	17.81	0.41	2.07	0.41	1.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	29.92	18.18	1.38	2.07	2.53	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	21.07	0.00	5.27	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	23.06	11.92	0.77	1.15	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	20.21	9.13	1.30	0.98	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	10.70	6.02	2.68	1.34	0.67	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	17.72	8.86	3.47	1.16	1.54	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	21.57	9.93	2.40	1.03	2.05	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	17.39	9.94	2.48	0.00	4.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	11.80	14.63	1.89	0.47	1.42	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	17.50	6.03	2.41	0.60	1.21	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	20.35	11.19	1.53	0.51	2.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	17.95	9.57	2.39	0.00	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	17.76	13.81	3.45	0.99	0.99	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	25.97	11.80	3.54	1.18	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	13.42	8.17	2.33	0.58	1.75	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	17.56	14.48	2.19	0.44	0.88	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	15.26	7.63	0.00	0.00	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	22.68	8.95	0.60	1.79	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	23.29	13.59	0.97	1.46	0.49	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	31.96	6.85	2.28	7.99	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	19.13	7.07	0.00	4.16	0.42	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	24.74	20.24	3.37	7.87	2.25	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	4.44	2.22	0.32	1.27	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	3.34	1.25	0.84	1.25	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	13.58	8.70	1.04	0.70	0.81	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	15.02	13.00	0.68	0.34	1.18	0.68
Hep-2 cells mock treated, biol_rep3	11900-125F1	12.97	10.47	1.82	0.46	0.68	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	14.43	8.85	1.64	0.44	0.55	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	10.96	9.67	1.29	0.86	0.86	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	14.64	10.76	0.86	0.43	0.22	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	12.20	11.58	0.62	0.87	0.37	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	9.26	7.21	0.86	0.17	0.17	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	13.46	9.29	0.64	0.64	0.64	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	9.51	9.51	2.24	2.80	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	27.70	16.01	3.03	1.73	0.43	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	37.01	13.22	2.64	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	52.91	30.33	4.59	8.47	1.06	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	29.79	9.44	2.18	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	40.56	19.58	2.27	1.92	0.52	0.52
Hepatocyte, donor1	11523-119I2	153.75	19.37	1.21	3.63	1.21	0.00
Hepatocyte, donor2	11603-120I1	123.89	42.02	8.62	2.15	0.00	5.39
Hepatocyte, donor3	11684-122I1	154.61	39.27	17.18	3.07	0.61	1.84
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	27.41	12.40	1.96	0.65	1.31	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	66.24	27.97	5.59	1.40	3.67	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	31.28	15.92	1.51	3.70	1.37	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	19.10	19.10	0.00	6.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	40.05	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	27.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	22.15	26.30	2.77	0.00	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	25.03	12.51	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	17.94	28.19	0.00	0.00	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	36.57	32.00	0.00	0.00	4.57	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	38.98	22.74	0.00	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	20.01	10.00	1.67	1.67	1.67	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	21.78	18.15	0.00	0.00	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	41.03	17.21	0.00	0.00	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	31.04	15.52	1.11	1.11	0.00	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	36.67	26.19	0.00	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	27.71	15.75	1.89	0.00	0.00	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	32.48	12.37	0.00	0.00	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	31.66	20.03	1.29	1.29	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	41.86	35.42	0.00	3.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	11.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	33.41	25.26	1.63	1.63	2.44	3.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	48.70	34.42	3.78	0.84	1.68	1.68
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	28.74	0.00	0.00	0.00	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	39.38	24.91	3.21	0.00	1.61	2.41
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	30.47	21.24	0.92	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	17.47	18.41	2.83	0.47	1.42	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	29.93	15.42	2.72	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	33.36	26.90	1.08	2.15	1.08	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	39.38	20.33	0.00	0.00	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	32.86	0.00	0.00	0.00	16.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	35.07	29.97	4.46	0.00	0.00	1.91
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	27.34	21.87	0.00	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	31.61	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	37.85	24.99	1.43	0.00	2.14	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	26.55	29.86	3.32	0.00	6.64	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	41.70	0.00	0.00	20.85	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	25.00	22.84	1.23	0.00	0.93	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	17.56	24.58	0.00	0.00	1.76	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	34.57	22.00	3.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	28.51	27.82	3.48	0.00	0.00	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	50.90	8.85	2.21	0.00	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	35.66	9.73	0.00	0.00	3.24	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	31.39	22.67	0.87	0.00	1.74	4.36
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	31.50	4.50	2.25	0.00	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	34.85	10.45	0.00	0.00	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	42.67	25.60	2.13	0.00	1.07	4.27
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	20.78	20.78	0.00	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	14.25	25.65	2.85	0.00	0.00	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	23.01	18.41	2.76	0.00	0.92	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	72.61	21.18	3.03	0.00	0.00	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	31.04	0.00	0.00	12.42	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	38.07	23.26	1.06	1.06	2.11	2.11
Keratinocyte - epidermal, donor1	11272-116H3	20.56	10.36	0.49	0.90	1.06	0.41
Keratinocyte - epidermal, donor2	11349-117G8	35.14	9.37	1.17	1.76	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	53.01	16.38	2.37	2.18	0.76	0.38
Keratinocyte - oral, donor1	11251-116E9	19.53	9.54	1.14	2.27	1.02	0.11
Keratocytes, donor1	11527-119I6	85.61	24.07	4.47	2.06	2.06	4.47
Keratocytes, donor2	11607-120I5	19.92	10.55	4.69	1.17	2.34	0.00
Keratocytes, donor3	11688-122I5	26.48	8.50	1.58	0.79	0.99	1.58
Krukenberg tumor cell line:HSKTC	10687-109F3	43.96	39.56	2.20	6.59	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	17.26	11.87	4.31	4.31	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	18.57	11.53	0.81	3.11	0.69	0.12
Lens Epithelial Cells, donor3	11690-122I7	50.66	23.01	3.03	3.53	1.31	0.61
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	25.26	15.18	2.61	1.78	1.19	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	15.91	7.26	1.12	1.12	1.12	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	25.19	13.54	1.57	2.36	1.89	0.94
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	16.67	6.99	3.23	0.54	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	14.50	7.88	1.58	0.32	0.95	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	21.67	11.21	2.26	1.73	1.40	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	13.54	7.39	0.82	0.41	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	11.63	8.60	1.52	1.52	1.77	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	20.41	10.42	0.56	1.13	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	11.47	6.72	1.98	0.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	17.26	8.14	2.13	0.39	0.78	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	14.63	10.18	0.74	0.93	1.11	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	12.89	8.71	1.05	1.39	0.70	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	15.98	7.16	1.43	0.00	1.67	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	23.62	10.58	1.37	2.33	1.10	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	16.63	10.78	0.92	0.62	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	14.03	6.86	0.94	0.31	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	25.44	9.33	2.93	1.65	1.83	0.91
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	15.80	10.20	1.65	0.33	0.00	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	17.87	6.74	1.46	1.46	2.05	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	23.65	9.96	1.99	0.75	0.75	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	12.61	9.21	1.94	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	15.08	5.12	0.54	0.81	1.08	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	22.40	11.05	2.12	1.51	1.36	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	15.55	9.33	1.04	1.56	0.52	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	15.08	7.33	2.09	1.05	1.05	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	24.21	12.33	2.71	1.20	1.05	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	15.13	9.63	3.44	2.06	2.06	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	17.69	6.21	1.51	1.88	0.38	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	19.09	9.33	1.06	1.70	1.06	0.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	17.93	9.69	0.00	0.48	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	11.91	6.28	0.99	0.99	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	21.43	11.40	1.36	1.36	0.74	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	19.62	10.74	2.22	1.85	1.85	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	12.35	6.42	0.49	0.74	0.74	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	17.19	9.76	1.92	1.79	1.79	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	15.76	10.29	0.64	1.61	1.61	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	15.83	5.48	0.91	0.91	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	20.58	12.46	1.54	0.28	1.12	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	9.96	7.82	2.13	2.49	1.42	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	11.63	7.27	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	21.63	9.49	2.02	1.87	1.40	1.09
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	16.47	9.67	0.36	2.51	0.36	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	12.74	5.55	0.65	1.96	0.65	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	22.84	10.36	1.18	0.71	1.18	0.71
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	26.85	17.57	1.36	2.10	1.36	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	14.60	4.61	0.77	0.26	0.51	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	17.01	8.95	3.88	1.19	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	11.33	11.33	4.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	14.58	14.58	1.53	0.77	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	20.04	6.68	2.23	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	13.54	15.66	2.12	0.42	0.42	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	13.36	7.74	1.41	0.70	2.11	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	21.48	13.08	3.74	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	10.31	10.82	1.55	0.00	1.55	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	13.08	8.33	3.57	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	15.83	18.10	1.58	1.36	1.13	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	13.38	7.56	2.33	0.58	0.00	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	17.56	8.10	0.90	0.45	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	16.80	13.41	3.25	1.22	1.90	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	12.84	13.87	3.08	0.00	1.03	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	15.88	8.82	1.41	2.12	1.06	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	16.66	9.33	2.00	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	9.17	13.24	1.53	0.00	1.53	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	19.21	10.94	1.33	1.07	1.60	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	17.19	13.60	1.89	0.57	0.76	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	11.04	9.20	4.29	0.00	1.23	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	20.39	15.49	3.26	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	16.24	12.08	1.46	1.67	1.04	1.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	17.94	12.61	1.12	0.28	0.84	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	14.42	15.46	3.09	0.00	2.06	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	15.10	15.10	2.61	1.16	0.58	2.32
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	12.56	13.75	2.69	0.90	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	15.49	12.17	1.66	0.00	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	15.55	19.09	3.18	0.00	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	12.17	10.69	2.95	0.74	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	19.57	8.06	3.45	2.30	3.45	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	22.26	19.19	2.69	1.15	1.15	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	18.12	11.89	2.83	0.00	1.13	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	13.95	9.85	1.64	0.82	2.46	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	19.43	11.30	3.16	1.36	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	17.24	13.64	0.72	0.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	15.68	9.71	0.75	2.24	2.99	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	21.55	20.44	1.49	1.49	1.86	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	10.77	12.06	0.86	0.43	0.43	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	20.55	14.56	2.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	21.66	23.32	3.00	1.00	1.00	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	12.67	12.67	0.60	1.21	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	18.49	15.64	2.84	0.00	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	20.28	13.06	2.41	1.37	1.03	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	17.18	17.71	1.61	2.15	1.61	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	20.20	12.79	3.37	2.69	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	20.00	13.33	2.59	0.74	1.48	1.48
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	20.93	16.28	2.33	0.00	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	19.04	11.64	1.06	1.06	0.00	3.17
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	18.41	20.41	2.40	1.60	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	14.54	13.81	2.18	0.00	2.91	2.91
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	16.86	14.56	6.13	0.77	1.53	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	17.76	11.84	0.99	2.47	2.47	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	13.17	6.59	2.82	1.88	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	14.08	15.08	1.51	1.51	3.02	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	14.42	11.27	2.70	0.90	0.90	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	15.49	12.05	6.88	0.00	5.16	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	16.03	17.37	1.34	1.34	0.89	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	17.21	15.25	4.69	0.78	0.78	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	17.15	10.56	0.66	0.66	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	16.61	15.57	2.08	2.08	0.52	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	21.00	13.56	3.94	1.31	1.31	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	11.18	13.98	1.68	1.12	2.24	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	12.81	14.13	1.77	0.44	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	19.29	16.20	1.93	1.93	0.77	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	9.62	12.15	2.03	1.01	2.53	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	16.82	17.30	0.96	1.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	14.71	12.32	0.80	0.00	1.19	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	12.15	12.15	1.22	1.22	0.61	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	12.45	11.07	0.00	0.00	0.69	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	16.72	15.58	3.04	1.14	1.14	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	13.43	14.46	0.52	1.03	1.55	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	10.88	15.12	3.02	0.00	0.60	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	15.53	18.38	3.49	1.90	0.32	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	11.73	12.26	2.67	2.13	0.53	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	14.37	8.62	1.72	1.15	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	17.48	14.91	2.57	0.51	1.54	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	11.32	10.61	3.54	0.00	0.71	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	14.75	13.05	3.40	1.70	1.13	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	13.31	15.81	3.74	0.42	1.66	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	18.01	11.75	0.78	0.00	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	14.61	11.69	2.92	0.84	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	15.33	13.01	2.32	0.93	1.39	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	12.04	14.05	2.01	1.34	0.67	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	20.85	19.25	5.88	2.14	1.60	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	25.46	21.82	2.02	0.81	2.83	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	10.10	8.26	4.59	0.00	0.92	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	19.56	9.78	2.67	0.89	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	18.24	23.93	1.71	1.14	0.57	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	17.64	18.41	2.30	2.30	1.53	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	21.34	20.79	2.74	0.55	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	26.73	24.05	5.35	1.34	0.45	2.67
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	32.75	28.86	3.90	1.82	2.86	1.82
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	18.57	17.24	6.63	0.00	2.65	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	27.02	27.02	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	15.95	4.33	1.37	0.68	1.60	0.23
Macrophage - monocyte derived, donor2	11313-117C8	23.31	9.73	2.57	2.94	0.55	0.18
Macrophage - monocyte derived, donor3	11389-118C3	19.79	6.42	2.10	3.54	1.31	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	23.36	13.81	0.53	2.12	0.00	1.06
Mallassez-derived cells, donor2	11929-125I3	92.38	32.17	5.23	4.28	1.27	0.79
Mallassez-derived cells, donor3	11930-125I4	47.26	18.76	2.08	2.50	1.39	0.83
Mammary Epithelial Cell, donor1	11273-116H4	32.88	23.02	2.79	2.29	2.49	1.00
Mammary Epithelial Cell, donor2	11350-117G9	24.90	17.37	3.47	0.87	1.45	0.29
Mammary Epithelial Cell, donor3	11422-118F9	20.45	11.97	1.50	2.99	1.50	0.50
Mast cell - stimulated, donor1	11487-119E2	31.19	14.91	4.07	9.49	0.68	2.03
Mast cell, donor1	11563-120D6	19.57	9.73	1.84	3.14	0.76	0.54
Mast cell, donor2	11565-120D8	21.69	8.62	2.38	4.16	0.89	0.89
Mast cell, donor3	11566-120D9	12.38	6.08	1.80	1.13	1.13	0.45
Mast cell, donor4	11567-120E1	13.83	6.56	2.66	2.30	0.53	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	31.72	20.07	4.99	3.88	2.00	0.78
Mast cell, expanded and stimulated, donor8	11942-126A7	60.12	22.18	4.67	7.00	1.17	1.75
Mast cell, expanded, donor5	11939-126A4	23.86	12.96	3.33	1.72	2.64	0.23
Mast cell, expanded, donor8	11941-126A6	11.55	4.69	1.34	1.00	1.00	0.17
Melanocyte - dark, donor1	11502-119F8	37.41	15.42	2.19	1.99	1.89	0.90
Melanocyte - dark, donor2	11582-120F7	35.65	12.81	2.42	2.08	0.35	0.69
Melanocyte - dark, donor3	11663-122F7	22.67	11.59	1.52	2.83	1.01	0.22
Melanocyte - light, donor1	11274-116H5	13.40	9.17	0.24	1.41	0.71	0.24
Melanocyte - light, donor2	11351-117H1	10.92	6.82	0.68	3.41	0.00	0.00
Melanocyte - light, donor3	11423-118G1	14.74	3.47	1.73	1.73	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	26.34	10.93	1.67	1.15	0.73	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	22.32	11.30	1.34	0.00	0.27	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	9.64	3.48	1.34	0.80	1.07	0.54
Meningeal Cells, donor1	11493-119E8	37.59	35.48	4.84	4.59	0.74	1.49
Meningeal Cells, donor2	11573-120E7	25.53	33.45	7.04	3.52	0.88	1.32
Meningeal Cells, donor3	11654-122E7	25.27	17.60	1.47	1.87	1.14	0.41
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	9.41	10.27	1.14	2.85	0.29	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	27.98	13.99	1.51	2.11	0.70	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	15.70	3.92	1.31	2.62	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	25.83	5.74	1.44	0.00	0.72	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	13.98	8.26	2.75	3.81	0.85	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	12.06	4.02	1.51	1.01	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	14.06	11.65	1.76	1.76	1.32	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	19.00	14.61	1.46	4.38	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	17.19	12.48	1.84	2.25	1.64	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	4.43	3.46	0.97	1.11	0.28	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	15.61	13.01	1.86	2.60	0.74	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	27.37	11.05	2.37	1.45	1.71	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	7.12	6.83	0.89	0.89	0.89	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	23.36	11.68	4.67	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	33.94	30.74	3.84	0.64	3.20	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	30.48	17.37	2.13	2.48	1.06	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	32.21	15.64	1.25	1.25	1.25	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	22.50	15.97	2.18	3.63	1.45	0.00
Mesothelial Cells, donor1	11247-116E5	31.82	13.26	2.39	3.45	1.33	0.53
Mesothelial Cells, donor2	12156-128G5	36.03	25.02	2.50	3.50	0.00	1.00
Mesothelial Cells, donor3	11402-118D7	18.07	9.90	1.81	3.76	0.72	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	29.71	9.45	0.00	6.75	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	21.67	7.14	3.20	2.46	1.48	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	10.31	3.24	0.88	1.47	0.29	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	20.74	6.91	3.46	13.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	14.57	5.89	1.55	2.79	0.93	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	9.13	2.49	1.45	1.04	0.21	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	11.58	9.26	2.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	10.01	6.01	1.00	2.50	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	12.57	1.86	1.40	2.33	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	19.47	0.00	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	11.79	4.67	1.02	1.42	0.41	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	10.30	3.17	2.38	3.56	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	0.00	0.00	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	13.27	2.65	0.00	3.54	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	9.88	1.90	0.38	1.52	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	13.16	5.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	10.40	3.18	1.06	1.27	0.64	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	9.21	1.84	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	14.01	2.98	1.79	1.79	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	8.38	3.35	0.00	3.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	33.95	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	10.04	3.76	1.25	1.76	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	7.37	1.43	0.24	1.43	0.71	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	21.01	8.29	0.55	2.76	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	13.35	4.84	0.69	0.92	0.23	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	11.99	2.52	0.84	0.84	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	14.68	4.08	0.82	1.83	0.61	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	10.08	4.51	1.50	2.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	11.34	2.67	0.00	1.78	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	10.51	3.72	0.22	0.44	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	8.11	2.53	0.51	1.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	24.85	4.97	0.00	4.97	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	12.23	4.08	0.54	2.72	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	10.29	3.82	1.47	1.18	0.59	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	17.45	7.63	0.00	4.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	11.53	1.44	2.40	0.96	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	11.61	3.20	0.40	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	32.91	2.74	0.00	2.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	10.01	3.00	1.50	0.50	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	26.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	10.19	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	14.45	4.38	0.44	0.88	0.44	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	17.66	0.00	0.00	3.31	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	17.93	5.12	0.00	5.76	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	13.88	4.71	1.49	1.49	0.00	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	20.18	2.78	2.09	2.78	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	17.68	11.05	0.00	4.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	19.15	3.42	0.68	1.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	13.57	3.50	0.88	1.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	17.40	6.04	1.07	1.78	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	11.50	4.77	1.68	0.56	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	15.38	2.08	0.42	3.33	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	16.90	4.66	0.00	0.58	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	10.56	3.02	0.30	0.90	0.30	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	11.69	4.17	1.67	1.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	7.22	0.00	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	8.31	5.54	2.77	0.92	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	14.80	2.28	0.57	1.14	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	14.09	3.45	0.83	1.66	0.55	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	9.85	3.63	0.26	0.52	0.52	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	10.72	3.00	2.14	0.00	0.86	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	13.34	3.81	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	7.21	3.47	1.33	0.80	0.27	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	10.48	5.69	0.90	2.99	0.60	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	7.20	4.80	0.14	0.85	0.28	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	7.96	4.78	0.96	2.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	12.83	4.20	1.11	2.65	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	9.86	6.45	1.90	3.41	0.38	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	7.95	5.11	0.28	0.85	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	16.71	2.46	1.23	0.98	0.25	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	14.34	8.47	1.96	0.00	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	9.70	6.47	0.59	1.18	0.59	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	11.82	4.32	0.86	2.59	0.58	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	7.42	5.77	0.82	2.47	0.82	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	5.96	5.96	2.08	0.89	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	3.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	1.78	3.56	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	11.83	2.63	1.97	1.97	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	11.57	3.16	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	11.27	3.76	0.59	0.99	0.40	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	8.38	1.86	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	9.76	1.88	0.38	1.88	0.75	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	11.99	3.73	1.33	0.80	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	11.99	4.07	1.47	1.58	0.45	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	7.37	2.21	1.47	1.47	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	12.82	1.10	2.20	1.83	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	9.33	1.56	0.00	0.00	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	1.07	1.60	0.53	1.60	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	10.10	3.03	1.01	1.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	7.17	0.42	0.42	0.42	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	1.36	1.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.27	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	0.81	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	5.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	6.52	0.00	0.00	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	0.00	0.00	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	44.60	16.80	2.37	2.37	1.08	1.72
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	20.90	7.84	1.05	0.00	0.52	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	5.34	4.67	2.00	1.33	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	8.76	6.68	0.42	0.83	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	29.47	24.34	4.37	4.18	1.14	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	22.34	15.96	3.19	12.77	1.60	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	3.40	1.36	1.36	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	60.64	18.38	5.51	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	2.09	1.67	0.84	1.26	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	8.14	9.07	1.39	1.86	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	4.32	4.32	0.54	0.54	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	9.04	5.47	0.84	1.89	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	89.08	0.00	22.27	0.00	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	3.97	2.48	0.50	0.99	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	5.14	1.62	0.81	2.44	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	4.53	3.63	1.59	2.49	0.00	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	3.27	4.57	1.31	1.63	0.33	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	10.75	4.74	0.55	0.91	0.73	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	2.12	2.12	1.06	0.53	1.06	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	1.80	1.80	0.00	1.20	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	13.78	5.91	2.63	2.30	1.31	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	3.09	2.11	0.81	1.63	0.33	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	9.88	6.70	1.59	1.23	0.18	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	4.22	1.41	0.00	5.63	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	2.76	3.22	0.46	1.84	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	6.11	1.61	2.25	1.29	0.00	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	16.21	9.66	3.79	1.38	0.69	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	118.84	27.81	10.11	0.00	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	12.48	6.24	1.34	1.34	0.22	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	4.66	3.39	0.42	0.85	0.42	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	7.60	4.75	0.24	1.19	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	3.00	2.58	0.43	1.29	0.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	81.25	27.08	9.03	9.03	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	2.33	3.33	0.00	2.00	0.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	9.92	9.02	0.90	1.80	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	6.75	2.38	0.79	0.79	0.00	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	4.64	1.86	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	10.22	6.05	1.51	2.65	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	5.87	5.87	0.33	0.98	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	7.41	6.10	1.74	0.87	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	8.59	6.78	0.45	2.26	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	4.41	1.76	1.76	1.76	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	3.99	4.65	0.00	1.33	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	3.97	1.98	0.99	1.49	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	4.21	3.83	0.38	0.77	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	14.82	9.68	0.91	1.81	1.51	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	13.48	7.29	2.43	1.55	0.00	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	4.07	2.71	1.36	0.00	0.68	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	81.75	15.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	1.83	1.22	0.00	3.05	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	5.67	6.61	0.31	2.52	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	3.93	2.72	1.21	1.82	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	4.75	2.37	0.00	0.00	1.58	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	49.88	6.80	0.00	1.13	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	75.87	5.06	10.12	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	29.81	10.93	1.24	1.49	0.75	1.24
Myoblast, donor2	11322-117D8	15.34	5.75	0.96	2.88	0.96	0.19
Myoblast, donor3	11398-118D3	24.89	14.29	2.02	2.86	0.34	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	29.48	10.51	1.90	0.73	0.73	1.17
Natural Killer Cells, donor1	11230-116C6	30.44	9.84	5.23	3.08	0.92	0.00
Natural Killer Cells, donor2	11311-117C6	17.49	8.44	0.90	1.51	1.21	0.60
Natural Killer Cells, donor3	11387-118C1	25.22	4.23	1.10	1.47	0.92	0.18
Neural stem cells, donor1	11275-116H6	23.95	18.87	1.45	3.63	2.54	0.36
Neural stem cells, donor2	11352-117H2	19.26	13.48	1.93	5.78	0.00	1.93
Neurons, donor1	11494-119E9	21.62	10.24	2.28	1.14	0.00	2.28
Neurons, donor2	11574-120E8	17.83	14.97	1.32	1.54	0.88	0.00
Neurons, donor3	11655-122E8	14.80	8.22	0.82	0.00	0.00	0.82
Neutrophils, donor1	11233-116C9	4.64	0.00	0.93	0.93	0.00	0.93
Neutrophils, donor2	11314-117C9	0.00	2.90	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	6.11	0.61	0.00	1.22	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	7.12	4.16	0.24	2.49	0.36	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	2.60	1.95	0.00	0.65	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	7.42	3.21	0.80	2.01	0.20	0.40
Olfactory epithelial cells, donor1	11933-125I7	7.43	2.89	0.55	1.10	0.14	0.14
Olfactory epithelial cells, donor2	11934-125I8	13.32	4.78	0.72	1.59	0.29	1.01
Olfactory epithelial cells, donor3	11935-125I9	8.97	5.45	0.79	1.14	0.23	0.11
Olfactory epithelial cells, donor4	11936-126A1	14.32	6.04	1.17	1.75	0.49	0.58
Oligodendrocyte - precursors, donor1	11496-119F2	36.11	21.67	0.60	0.00	1.81	2.41
Osteoblast - differentiated, donor1	11276-116H7	9.15	4.25	0.85	1.28	0.43	0.85
Osteoblast - differentiated, donor2	11353-117H3	6.86	2.29	1.14	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	17.38	6.21	1.24	0.62	0.00	1.86
Osteoblast, donor1	11277-116H8	27.95	11.92	2.15	1.95	0.59	0.39
Osteoblast, donor2	11354-117H4	49.16	18.96	2.81	2.81	0.70	0.00
Osteoblast, donor3	11426-118G4	29.15	16.00	2.31	2.31	0.36	0.71
Pancreatic stromal cells, donor1	11249-116E7	18.53	7.50	1.26	1.68	0.67	0.25
Pericytes, donor1	11491-119E6	13.02	10.24	3.34	4.12	0.45	0.11
Pericytes, donor2	11571-120E5	18.11	8.38	3.40	3.85	0.91	0.91
Pericytes, donor3	11652-122E5	35.40	16.48	2.24	3.46	1.22	0.61
Perineurial Cells, donor1	11499-119F5	29.95	15.48	2.83	2.83	1.36	0.57
Perineurial Cells, donor2	11579-120F4	50.97	22.36	2.67	3.96	1.84	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	20.08	7.01	2.23	0.96	0.00	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	13.22	1.71	0.49	0.24	0.73	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	13.85	5.95	1.04	0.65	0.91	0.13
Placental Epithelial Cells, donor1	11278-116H9	28.46	12.68	0.96	0.96	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	4.44	7.76	0.00	2.22	2.22	1.11
Placental Epithelial Cells, donor3	11427-118G5	16.49	4.52	0.98	2.16	0.20	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	17.72	7.91	1.27	2.22	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	24.39	9.57	1.31	1.69	0.00	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	64.61	16.97	3.26	1.17	1.31	1.31
Preadipocyte - breast, donor2	11328-117E5	29.49	9.23	2.03	1.80	0.68	1.80
Preadipocyte - omental, donor1	11468-119C1	36.98	11.61	2.02	1.49	0.53	1.81
Preadipocyte - omental, donor2	11329-117E6	23.13	11.35	0.87	2.18	0.87	0.44
Preadipocyte - omental, donor3	11403-118D8	58.45	20.48	2.72	3.01	1.15	1.86
Preadipocyte - perirenal, donor1	11469-119C2	15.75	9.84	3.94	3.94	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	35.63	12.59	0.61	5.53	0.92	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	35.77	9.03	1.95	3.36	1.77	1.06
Preadipocyte - subcutaneous, donor3	11428-118G6	21.80	13.11	1.19	2.55	0.51	0.68
Preadipocyte - visceral, donor1	11280-116I2	32.42	16.86	1.86	2.61	1.49	0.93
Preadipocyte - visceral, donor2	11357-117H7	28.53	12.42	0.46	5.06	1.38	0.46
Preadipocyte - visceral, donor3	11429-118G7	17.45	11.08	1.46	3.55	0.63	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	100.02	26.55	4.07	2.11	3.62	2.72
Prostate Epithelial Cells, donor2	11331-117E8	18.28	12.19	0.68	2.17	1.35	0.27
Prostate Epithelial Cells, donor3	11404-118D9	26.03	20.33	2.27	0.49	2.27	1.65
Prostate Stromal Cells, donor1	11254-116F3	50.46	18.34	2.28	2.05	0.46	1.03
Prostate Stromal Cells, donor2	11332-117E9	34.60	12.55	0.90	1.61	1.08	1.61
Prostate Stromal Cells, donor3	11405-118E1	13.03	5.84	0.83	1.67	0.73	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	47.08	26.28	6.93	4.01	5.11	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	22.94	17.05	2.77	1.25	2.77	0.28
Renal Epithelial Cells, donor1	11517-119H5	19.27	15.72	1.52	0.51	1.01	1.01
Renal Epithelial Cells, donor2	11597-120H4	36.28	22.76	5.69	0.71	2.85	0.71
Renal Epithelial Cells, donor3	11678-122H4	27.84	28.90	2.65	1.69	3.39	0.32
Renal Glomerular Endothelial Cells, donor1	11514-119H2	17.70	12.26	3.40	0.00	0.68	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	20.48	14.69	2.02	2.16	0.81	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	45.51	28.64	2.66	1.33	2.00	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	23.96	11.31	1.33	1.33	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	41.82	26.41	3.96	3.30	2.64	0.88
Renal Mesangial Cells, donor2	11598-120H5	38.25	26.33	4.39	4.39	4.39	0.00
Renal Mesangial Cells, donor3	11679-122H5	25.80	17.20	3.88	2.50	1.39	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	31.94	23.08	5.10	1.34	2.42	1.07
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	32.47	19.40	4.22	1.69	0.84	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	28.35	22.56	2.70	2.31	2.89	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	16.08	11.41	2.07	0.52	0.78	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	24.73	15.35	3.70	2.84	0.85	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	31.90	17.50	5.15	4.12	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	20.57	9.79	1.51	0.75	1.25	2.01
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	28.06	12.56	2.54	2.27	0.53	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	18.76	53.60	3.57	0.00	1.79	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	18.16	15.96	2.75	0.00	0.00	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	27.84	29.58	5.22	0.58	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	31.99	56.82	3.90	0.91	2.08	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	27.01	31.78	3.08	0.60	1.49	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	38.03	49.19	3.01	0.67	1.56	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	42.79	57.31	5.71	0.62	2.36	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	27.15	31.70	3.50	0.82	1.28	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	36.29	41.60	3.00	0.46	1.85	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	23.00	30.12	3.29	0.82	0.96	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	34.19	35.10	2.42	0.30	1.66	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	38.35	46.05	3.58	0.90	1.79	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	23.38	30.56	2.87	1.00	1.43	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	29.08	36.06	3.43	0.43	1.18	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	35.18	44.25	3.54	0.44	1.77	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	26.96	23.51	3.82	0.38	0.19	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	31.68	39.31	3.07	0.28	1.40	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	36.27	46.23	2.63	0.56	1.88	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	27.87	37.29	3.98	0.13	0.53	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	31.54	38.74	3.41	0.29	1.85	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	30.94	37.81	2.48	0.19	0.95	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	23.17	35.99	2.88	0.32	1.07	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	25.79	33.64	2.24	0.28	0.84	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	37.26	39.48	1.54	1.20	1.54	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	28.81	34.28	4.38	1.09	0.91	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	25.63	33.36	2.82	0.25	1.59	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	33.71	44.86	4.03	0.13	1.88	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	20.99	26.65	2.59	0.00	0.71	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	23.21	34.52	2.38	0.40	1.19	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	35.31	47.24	3.98	0.23	1.64	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	22.39	31.10	3.32	0.83	1.04	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	22.78	34.07	1.99	0.00	0.88	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	31.96	39.48	2.51	0.42	1.25	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	24.23	32.03	3.90	0.81	0.67	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	28.27	42.74	1.87	1.19	1.36	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	32.58	38.94	3.86	0.96	2.70	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	26.65	24.93	3.61	0.69	0.52	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	30.73	37.45	3.70	1.10	1.92	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	33.98	39.73	1.64	0.49	1.48	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	23.52	21.82	5.28	0.34	1.36	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	31.51	40.24	3.70	0.59	2.66	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	31.19	33.05	4.26	0.53	1.33	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	19.08	35.53	2.49	0.97	0.83	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	25.00	36.91	3.57	0.00	1.43	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	31.24	43.73	4.03	0.60	2.02	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	20.06	33.34	2.17	0.28	1.13	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	31.79	35.98	2.45	0.00	1.40	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	28.71	31.73	2.72	0.00	3.02	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	29.37	38.43	3.55	0.61	1.10	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	50.22	48.61	3.93	0.15	2.77	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	43.20	41.37	6.08	1.22	2.43	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	31.65	28.93	3.32	0.30	0.90	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	45.01	52.02	5.20	0.23	2.94	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	46.43	44.93	2.70	0.90	2.10	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	48.65	62.46	7.44	0.83	2.01	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	55.07	46.10	4.70	0.00	2.13	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	43.27	42.07	4.21	0.00	0.60	0.00
Schwann Cells, donor1	11498-119F4	16.74	16.74	4.51	3.57	0.75	0.38
Schwann Cells, donor2	11578-120F3	17.01	6.80	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	15.55	9.64	1.53	1.53	0.88	0.66
Sebocyte, donor1	11220-116B5	37.80	29.58	3.83	2.19	1.10	0.00
Sebocyte, donor2	11301-117B5	17.00	9.65	0.00	1.38	1.84	0.00
Sebocyte, donor3	11378-118B1	7.21	4.74	0.62	0.62	0.82	0.00
Sertoli Cells, donor1	11255-116F4	56.32	23.19	3.31	3.31	3.31	0.00
Sertoli Cells, donor2	11333-117F1	8.47	8.47	0.00	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	24.90	9.41	2.11	0.70	1.23	2.20
Skeletal Muscle Cells, donor2	11358-117H8	67.95	8.67	0.72	0.72	0.00	2.89
Skeletal Muscle Cells, donor3	11430-118G8	22.57	11.70	2.51	1.67	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	18.69	14.92	3.30	2.36	1.26	0.16
Skeletal Muscle Cells, donor5	11455-119A6	16.35	13.38	2.68	2.68	1.04	0.59
Skeletal Muscle Cells, donor6	11459-119B1	18.93	14.31	3.08	1.39	0.62	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	14.49	8.44	1.13	3.02	0.38	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	10.56	6.71	1.14	2.28	0.57	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	25.79	11.41	2.38	2.58	1.88	0.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	29.07	6.74	1.85	1.10	0.42	1.35
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	16.65	8.69	0.72	0.72	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	11.28	6.33	1.79	2.75	0.55	0.83
Skin - palm, donor1	10286-104F7	13.43	2.69	0.00	5.37	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	13.55	9.08	1.44	2.02	0.58	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	20.45	5.73	3.27	0.82	2.45	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	6.88	6.10	0.91	0.78	0.26	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	42.26	27.11	2.50	0.97	1.67	2.22
Small Airway Epithelial Cells, donor2	11334-117F2	29.82	17.72	2.11	1.41	1.41	0.98
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	51.80	35.73	4.02	2.11	2.11	1.06
Small Airway Epithelial Cells, donor3	11406-118E2	65.88	37.48	4.27	2.25	2.55	3.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	3.09	0.62	0.31	1.54	0.31	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	61.81	22.01	5.11	4.00	0.67	2.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	19.99	12.34	1.76	2.35	1.18	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	26.96	18.78	2.65	3.31	0.66	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	32.68	23.63	1.58	3.15	1.18	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	25.49	16.22	1.55	1.55	0.77	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	3.00	1.00	1.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	42.58	17.83	2.26	3.86	1.20	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	23.05	9.53	1.11	2.44	1.11	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	34.44	16.77	2.69	3.58	2.05	0.51
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	24.74	13.35	2.93	2.60	2.28	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	18.61	11.81	2.07	2.95	0.89	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	16.66	8.83	1.71	2.28	1.71	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	14.97	10.41	1.14	1.46	1.46	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	10.35	3.65	2.13	0.30	0.91	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	29.80	15.15	3.03	3.79	1.77	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	48.97	97.93	30.60	6.12	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	21.93	11.92	0.95	1.43	0.95	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	17.99	7.96	1.03	1.62	0.74	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	17.86	7.10	1.94	1.08	0.65	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	24.25	12.07	2.10	1.68	0.73	0.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	40.84	18.25	1.24	3.71	1.55	0.62
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	20.48	11.86	2.16	2.16	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	30.78	17.93	2.69	5.08	1.20	1.20
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	32.43	20.14	2.39	1.37	0.68	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	13.11	6.99	1.41	1.49	0.79	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	16.30	8.15	1.11	2.21	0.70	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	27.99	13.88	1.59	3.64	1.37	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	25.36	9.66	1.21	1.21	1.21	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	36.03	27.82	2.65	2.12	1.85	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	13.85	13.32	2.66	2.40	1.20	1.07
Smooth Muscle Cells - Prostate, donor2	11335-117F3	26.55	15.78	1.13	2.63	0.38	1.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	10.15	2.79	0.51	1.27	0.76	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	30.15	13.57	2.26	3.32	0.75	1.06
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	19.50	5.25	1.50	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	56.86	65.90	14.21	0.00	2.58	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	51.16	18.14	2.33	3.26	2.33	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	33.32	8.08	0.00	3.53	0.00	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	21.62	12.22	1.57	2.51	0.63	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	5.01	4.42	0.00	1.77	0.88	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	18.08	14.33	1.92	2.33	1.17	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	5.14	2.80	0.00	2.34	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	30.08	13.10	0.58	3.17	0.72	0.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	28.81	11.22	0.51	2.80	0.51	1.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	18.80	8.09	2.26	4.51	0.38	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	22.92	14.11	2.79	1.82	1.68	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	28.07	18.52	3.85	1.76	1.51	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	7.14	6.19	0.95	0.00	0.95	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	28.38	13.95	1.96	1.71	1.71	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	11.49	4.20	1.33	3.76	0.00	1.10
Smooth Muscle Cells - Uterine, donor3	11466-119B8	23.99	11.12	1.46	2.34	1.46	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	7.58	3.69	1.17	1.36	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	10.31	5.82	0.79	0.26	0.53	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	6.32	3.35	0.37	0.74	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	12.94	5.03	2.16	1.44	0.72	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	11.36	6.53	0.85	1.42	0.28	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	11.03	4.73	1.58	0.79	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	8.13	4.32	1.78	1.02	0.51	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	4.39	3.99	0.80	0.80	0.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	6.27	3.34	1.67	0.42	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	7.79	5.50	1.38	0.46	0.00	0.00
Synoviocyte, donor1	11291-117A4	20.54	6.40	0.67	0.84	0.00	0.17
Synoviocyte, donor2	11368-117I9	8.55	3.69	0.34	1.01	0.00	0.17
Synoviocyte, donor3	11440-118H9	6.26	4.02	1.34	0.45	0.45	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	33.23	20.73	4.65	1.79	0.36	2.86
Trabecular Meshwork Cells, donor2	11612-122A1	15.86	5.95	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	14.59	10.42	1.85	1.16	1.39	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	32.54	18.78	2.22	2.08	2.22	0.72
Tracheal Epithelial Cells, donor2	11369-118A1	17.78	6.57	0.77	2.32	0.77	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	21.19	20.62	4.01	1.72	1.72	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	27.93	13.78	2.58	2.46	1.60	0.12
Urethra, donor2	10319-105A4	16.19	8.99	1.80	0.00	0.00	1.80
Urothelial Cells, donor1	11520-119H8	22.32	10.89	3.19	2.13	2.39	0.27
Urothelial Cells, donor2	11600-120H7	24.84	11.62	3.61	2.00	0.80	0.00
Urothelial Cells, donor3	11681-122H7	24.30	9.63	3.21	0.69	1.15	0.23
Urothelial cells, donor0	11216-116B1	37.89	15.38	3.12	2.90	2.01	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	10.68	5.34	1.78	0.89	0.00	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	7.15	8.58	0.00	2.86	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	6.16	4.11	1.37	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	12.40	3.44	0.69	0.69	0.34	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	10.46	6.97	1.74	1.74	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	6.25	1.04	2.08	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	8.26	3.67	1.84	1.84	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	12.78	2.74	0.00	0.00	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	25.17	12.58	2.96	0.99	1.11	0.49
Wilms' tumor cell line:HFWT	10597-108E3	72.16	16.72	1.76	1.76	1.76	14.96
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	25.42	30.17	3.07	0.84	1.96	0.84
achilles tendon, donor2	10292-104G4	10.33	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	41.05	20.65	2.55	1.27	0.00	1.78
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	39.70	12.77	2.09	1.16	1.16	1.39
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	38.58	16.38	2.02	0.36	1.19	1.31
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	58.78	31.57	3.54	2.72	2.72	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	23.89	13.49	3.65	0.28	0.56	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	23.47	15.23	1.69	0.63	1.48	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	198.44	34.30	7.35	4.63	1.63	9.53
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	47.15	8.81	3.53	2.64	0.00	3.53
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	25.73	6.13	2.04	0.00	1.63	2.04
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	26.02	6.60	1.55	1.55	1.16	3.11
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	29.07	15.09	3.68	1.10	0.92	1.66
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	19.50	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	24.63	8.37	3.49	0.70	0.46	2.32
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	32.10	15.02	3.88	0.00	1.04	1.55
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	69.55	19.00	3.51	2.63	0.58	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	29.28	8.37	3.25	1.86	0.46	2.32
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	18.51	11.10	2.47	0.82	0.41	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	39.29	15.65	4.60	0.92	0.61	3.68
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	95.58	21.76	4.69	5.12	0.00	2.13
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	50.35	16.38	3.34	1.52	0.91	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	88.58	18.29	4.57	2.17	1.20	3.61
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	22.27	9.13	1.78	0.45	1.11	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	12.34	8.01	1.67	0.67	1.67	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	22.30	22.30	7.43	0.00	5.57	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	53.49	25.24	3.01	3.77	0.75	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	27.48	14.39	4.36	1.31	0.44	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	46.86	15.00	1.87	1.87	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	29.67	14.37	2.35	3.06	0.71	0.00
adipose tissue, adult, pool1	10010-101C1	15.51	9.62	0.78	1.86	0.47	0.00
adipose, donor1	10184-103D4	49.84	52.19	9.97	2.35	5.86	1.76
adipose, donor2	10185-103D5	8.92	10.95	1.62	1.62	1.22	0.41
adipose, donor3	10186-103D6	13.61	18.52	3.27	1.09	2.45	0.54
adipose, donor4	10187-103D7	24.27	39.00	6.07	0.87	4.33	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	32.20	51.61	6.15	3.31	6.15	0.63
adrenal gland, adult, pool1	10081-102A9	0.00	7.28	3.64	3.64	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	21.88	20.01	2.93	0.40	1.60	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	19.29	13.58	2.14	1.79	0.36	0.71
amniotic membrane cells, donor1	12235-129G3	13.22	9.04	1.85	2.78	0.93	0.00
amniotic membrane cells, donor2	12236-129G4	10.82	6.09	2.03	0.34	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	8.54	3.54	1.47	2.65	0.29	0.00
amygdala - adult, donor10196	10167-103B5	27.27	9.49	5.93	7.11	2.37	0.00
amygdala, adult, donor10252	10151-102I7	35.48	8.31	3.65	3.45	1.62	0.20
amygdala, newborn, donor10223	10360-105E9	20.98	9.36	2.26	1.94	0.97	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	19.99	8.53	2.29	1.40	1.02	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	6.84	10.37	1.10	0.66	1.10	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	35.07	25.39	3.01	1.67	3.01	1.67
aorta, adult, pool1	10052-101G7	19.61	6.47	1.57	2.75	0.59	0.20
appendix, adult	10189-103D9	24.45	9.31	4.27	0.78	0.39	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	16.51	7.91	0.69	0.69	0.69	1.03
artery, adult	10190-103E1	10.87	1.36	0.00	0.00	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	25.64	31.29	3.62	4.35	2.75	0.87
b cell line:RPMI1788	10427-106D4	34.94	19.48	3.27	1.34	1.49	0.74
basal cell carcinoma cell line:TE 354.T	10702-109G9	45.50	14.70	1.39	3.61	0.83	1.11
bile duct carcinoma cell line:HuCCT1	10432-106D9	33.84	27.88	3.27	1.39	2.28	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	42.18	12.05	2.18	0.33	0.17	2.85
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	22.37	8.39	0.00	0.56	1.68	0.56
bladder, adult, pool1	10011-101C2	22.27	9.78	1.74	0.87	1.09	0.22
blood, adult, pool1	10053-101G8	6.64	4.43	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	19.70	8.56	0.00	1.71	0.00	0.00
bone marrow, adult	10192-103E3	14.17	6.07	0.67	0.67	0.00	0.67
brain, adult, donor1	10084-102B3	26.65	5.13	2.05	5.13	1.03	1.03
brain, adult, pool1	10012-101C3	29.62	11.25	3.90	5.23	1.67	0.22
brain, fetal, pool1	10085-102B4	8.01	13.36	0.00	0.00	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	55.17	21.14	3.63	0.99	1.32	2.31
breast carcinoma cell line:MDA-MB-453	10419-106C5	46.56	20.35	3.37	3.25	1.00	1.12
breast, adult, donor1	10080-102A8	23.36	8.21	2.53	3.16	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	28.96	13.85	4.57	4.07	1.65	2.79
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	29.38	24.12	2.47	3.09	3.09	1.55
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	24.86	24.86	5.76	4.37	2.07	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	30.02	25.18	1.69	1.69	1.45	0.24
carcinoid cell line:NCI-H1770	10703-109H1	19.28	18.34	1.41	0.47	3.29	0.00
carcinoid cell line:NCI-H727	10735-110B6	88.27	53.82	5.91	3.17	3.17	2.41
carcinoid cell line:SK-PN-DW	10719-109I8	1.27	2.54	0.32	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	60.42	23.42	4.79	3.19	1.60	2.66
caudate nucleus - adult, donor10196	10177-103C6	17.27	9.21	3.45	4.61	2.30	0.00
caudate nucleus, adult, donor10252	10164-103B2	60.40	14.56	4.02	1.34	2.34	1.00
caudate nucleus, adult, donor10258	10379-105H1	22.16	12.99	7.64	0.76	3.06	0.76
caudate nucleus, newborn, donor10223	10354-105E3	17.95	9.52	2.93	0.73	0.73	0.37
cerebellum - adult, donor10196	10173-103C2	11.65	8.74	0.00	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	17.29	10.25	2.78	0.85	2.99	0.21
cerebellum, adult, pool1	10083-102B2	17.94	12.42	2.41	2.76	1.38	0.00
cerebellum, newborn, donor10223	10357-105E6	21.59	9.96	2.49	0.00	0.83	0.00
cerebral meninges, adult	10188-103D8	26.73	10.59	4.79	4.29	2.52	0.50
cerebrospinal fluid, donor2	10294-104G6	9.50	4.39	0.00	1.46	0.73	0.73
cervical cancer cell line:D98-AH2	10552-107I3	64.70	25.16	5.90	0.29	1.73	5.32
cervical cancer cell line:ME-180	10553-107I4	36.13	16.57	2.32	0.66	0.50	1.33
cervix, adult, pool1	10013-101C4	19.53	9.45	3.15	2.31	0.84	0.42
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	81.93	50.86	5.43	0.84	2.51	0.84
chondrosarcoma cell line:SW 1353	10700-109G7	37.88	20.90	1.31	0.00	1.31	2.61
choriocarcinoma cell line:BeWo	10423-106C9	57.17	32.31	5.10	0.37	1.74	1.24
choriocarcinoma cell line:SCH	10785-110H2	30.56	18.73	3.33	2.22	3.08	1.23
choriocarcinoma cell line:T3M-3	10618-108G6	31.31	30.83	5.46	1.90	4.27	1.19
chorionic membrane cells, donor1	12238-129G6	17.67	15.39	2.85	0.00	0.85	0.28
chorionic membrane cells, donor2	12239-129G7	30.43	17.00	2.59	2.49	1.79	0.40
chorionic membrane cells, donor3	12240-129G8	17.58	9.34	2.20	1.65	1.10	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	12.12	4.04	1.01	1.01	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	25.93	4.99	0.58	1.34	0.19	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	21.96	7.81	2.11	1.69	1.06	1.69
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	23.37	19.00	3.34	1.03	1.03	2.57
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	27.09	13.30	2.18	0.73	1.21	0.97
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	26.06	14.05	1.63	1.02	1.02	2.04
chronic myelogenous leukemia cell line:K562	10454-106G4	40.63	28.27	2.06	0.59	1.47	2.65
chronic myelogenous leukemia cell line:KU812	10409-106B4	50.04	22.94	2.87	1.82	2.09	1.56
clear cell carcinoma cell line:JHOC-5	10638-108I8	31.09	19.66	4.34	2.29	1.14	1.83
clear cell carcinoma cell line:TEN	10636-108I6	60.38	28.46	3.82	2.26	2.08	1.91
colon carcinoma cell line:CACO-2	10513-107D9	46.68	23.98	3.48	1.83	3.11	1.10
colon carcinoma cell line:COLO-320	10420-106C6	70.70	25.47	5.32	1.14	3.42	3.04
colon, adult, donor1	10082-102B1	21.42	9.52	2.38	4.76	0.00	0.00
colon, adult, pool1	10014-101C5	21.86	9.05	2.23	2.00	0.47	0.24
colon, fetal, donor1	10070-101I7	4.33	1.85	1.85	0.00	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	105.42	32.08	9.17	0.00	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	121.53	37.39	7.22	4.25	0.85	4.67
cord blood derived cell line:COBL-a 24h infection	10453-106G3	124.82	32.15	5.74	5.89	0.91	5.28
cord blood derived cell line:COBL-a untreated	10449-106F8	144.82	35.25	6.20	5.92	2.96	4.09
corpus callosum, adult, pool1	10042-101F6	35.38	12.05	2.65	3.87	0.66	0.66
cruciate ligament, donor2	10295-104G7	11.35	4.05	1.62	0.81	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	5.62	1.61	1.61	1.61	0.00	0.00
diencephalon, adult	10193-103E4	21.60	13.20	4.08	1.68	1.68	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	10.56	5.05	0.92	0.23	0.00	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	35.65	42.57	5.90	3.33	4.10	1.80
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	42.61	17.09	2.65	0.72	0.72	1.44
ductus deferens, adult	10196-103E7	49.83	25.42	8.47	3.49	2.99	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	14.40	7.20	4.32	4.32	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	33.10	9.56	4.41	2.21	2.94	0.74
dura mater, adult, donor1	10041-101F5	28.91	10.57	2.48	5.04	1.57	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	9.10	16.66	0.44	0.22	0.00	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	19.49	18.91	1.43	0.00	1.00	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	19.73	9.87	2.47	1.23	1.85	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	9.69	8.78	1.51	0.00	1.21	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	19.14	12.04	1.23	1.85	1.23	0.62
embryonic pancreas cell line:2C6	10603-108E9	26.27	5.25	2.63	2.63	2.63	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	36.54	42.57	3.35	0.67	3.69	1.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	37.88	24.65	3.26	1.63	1.99	1.09
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	25.41	11.26	1.61	1.13	0.48	0.96
epidermoid carcinoma cell line:A431	10426-106D3	21.68	13.56	1.56	0.33	1.00	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	25.96	16.83	1.65	0.66	1.76	0.44
epididymis, adult	10197-103E8	41.65	15.70	2.72	4.81	0.63	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	50.92	29.45	7.63	2.48	3.37	3.55
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	124.26	23.99	4.33	1.97	0.39	12.98
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	16.64	17.30	1.18	0.66	1.57	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	18.60	17.13	2.26	0.69	0.98	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	15.24	16.13	0.45	0.67	2.46	0.45
esophagus, adult, pool1	10015-101C6	13.06	8.60	1.70	0.96	0.32	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	94.30	26.30	3.51	0.75	1.75	9.52
eye - muscle inferior rectus, donor1	10272-104E2	24.15	2.41	2.41	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	6.31	2.10	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	5.95	7.44	0.00	0.00	1.49	0.00
eye - muscle superior, donor2	10297-104G9	6.88	5.73	2.29	1.15	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	2.91	2.91	1.46	1.46	0.00	1.46
eye, fetal, donor1	10054-101G9	9.41	7.63	2.03	1.53	1.02	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	21.67	21.93	3.21	0.90	1.03	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	19.71	27.30	3.09	3.09	2.61	0.47
frontal lobe, adult, pool1	10040-101F4	39.12	15.20	4.79	7.13	2.63	0.47
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	22.82	17.41	3.30	1.80	2.40	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	108.90	83.30	11.43	2.10	8.32	1.65
gall bladder, adult	10198-103E9	26.80	10.62	1.69	1.93	0.48	0.48
gamma delta positive T cells, donor1	11937-126A2	35.43	12.88	6.98	2.68	3.22	0.00
gamma delta positive T cells, donor2	11938-126A3	30.25	9.71	2.61	1.12	2.24	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	39.50	35.70	1.27	0.00	1.27	0.84
gastric adenocarcinoma cell line:MKN45	10612-108F9	420.68	91.10	22.63	5.61	4.45	23.79
gastric cancer cell line:AZ521	10549-107H9	101.98	46.89	6.39	2.79	2.62	2.30
gastric cancer cell line:GSS	10560-108A2	19.22	44.85	8.24	0.00	1.83	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	61.91	32.67	2.74	0.46	1.60	1.83
giant cell carcinoma cell line:LU65	10487-107B1	21.92	9.98	1.15	0.23	0.46	1.03
giant cell carcinoma cell line:Lu99B	10433-106E1	13.58	11.06	2.24	1.40	1.26	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	12.22	7.48	0.75	0.25	0.25	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	19.00	15.31	1.69	0.74	1.37	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	17.70	13.34	1.69	0.84	0.84	0.00
glioblastoma cell line:T98G	10485-107A8	24.39	17.99	2.32	1.99	1.66	0.55
glioma cell line:GI-1	10413-106B8	208.24	43.05	6.15	2.34	2.64	4.69
globus pallidus - adult, donor10196	10175-103C4	19.68	10.20	5.10	2.92	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	45.40	14.16	5.13	1.95	1.71	0.24
globus pallidus, adult, donor10258	10367-105F7	5.48	5.48	4.11	2.74	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	16.52	11.19	2.66	2.13	2.13	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	166.41	36.71	4.89	17.13	0.00	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	31.36	15.68	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	27.20	11.52	2.56	1.28	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	16.53	24.79	5.05	1.38	0.00	1.38
hIPS +CCl2, biol_rep2	14384-156C1	11.43	17.38	6.86	0.91	0.00	1.37
hIPS +CCl2, biol_rep3	14385-156C2	14.17	23.83	7.09	0.00	0.64	0.64
hIPS, biol_rep1	14380-156B6	5.75	31.62	4.31	0.00	0.00	1.44
hIPS, biol_rep2	14381-156B7	11.66	32.92	9.60	0.00	0.69	0.00
hIPS, biol_rep3	14382-156B8	25.38	17.66	6.62	4.41	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	18.96	10.63	0.57	1.44	1.72	0.29
heart - mitral valve, adult	10205-103F7	20.93	5.38	2.39	2.39	1.49	0.00
heart - pulmonic valve, adult	10206-103F8	11.24	5.23	1.57	1.05	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	97.42	24.98	8.33	10.82	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	41.83	20.41	5.71	2.65	1.22	0.82
heart, adult, diseased, donor1	10051-101G6	28.96	9.37	0.85	3.41	0.85	0.43
heart, adult, pool1	10016-101C7	25.76	11.27	2.76	1.38	1.84	0.00
heart, fetal, pool1	10046-101G1	23.41	11.91	2.36	0.82	0.72	0.41
hepatic mesenchymal tumor cell line:LI90	10778-110G4	32.09	16.35	2.16	3.09	1.23	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	66.59	17.84	2.38	1.19	0.00	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	70.83	16.24	2.65	0.77	1.10	1.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	79.26	20.88	3.28	1.58	1.82	2.18
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	67.71	20.92	1.82	1.72	1.31	2.12
hepatoma cell line:Li-7	10484-107A7	59.72	28.69	2.11	0.67	1.22	1.78
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	20.00	16.68	2.11	0.50	1.31	0.80
hippocampus - adult, donor10196	10169-103B7	24.60	7.57	3.79	1.89	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	36.33	13.27	3.88	4.29	0.61	0.20
hippocampus, adult, donor10258	10374-105G5	16.43	8.47	5.48	4.98	1.00	0.50
hippocampus, newborn, donor10223	10363-105F3	18.68	4.93	2.11	1.41	1.06	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	35.40	39.67	9.77	0.61	3.05	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	23.17	21.40	3.93	0.39	1.77	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	26.66	29.96	5.08	0.51	2.79	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	12.97	21.99	3.95	1.13	2.26	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	11.62	21.43	3.61	1.55	2.32	1.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	19.74	18.22	4.56	1.52	1.14	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	9.05	15.18	2.92	1.46	2.04	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	8.83	15.30	1.72	0.86	1.94	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	9.18	19.19	2.09	1.67	2.09	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	26.05	17.05	1.89	1.89	0.71	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	13.82	18.00	1.93	1.93	1.29	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	24.24	21.55	3.37	3.37	0.67	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	20.19	25.82	3.13	0.78	1.10	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	25.06	27.51	1.47	0.49	1.97	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	21.82	27.93	3.49	0.87	0.87	4.36
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	22.34	24.63	2.29	0.38	1.53	1.15
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	21.80	20.93	3.49	0.44	2.18	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	25.99	15.99	4.00	1.00	2.00	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	12.06	12.62	1.88	1.70	2.64	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	12.73	10.00	2.73	1.82	0.91	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	10.96	15.04	3.13	1.25	1.25	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	18.94	10.45	1.96	2.61	1.47	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	17.13	11.61	1.74	2.03	1.45	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	15.25	15.25	3.59	1.79	0.90	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	21.80	19.77	3.69	0.37	1.11	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	19.97	15.69	1.71	0.29	0.29	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	37.56	26.54	6.94	1.22	3.27	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	20.07	12.67	3.87	2.11	2.46	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	15.84	12.35	3.17	1.27	2.22	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	17.85	14.53	3.33	0.61	0.91	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	11.89	7.24	2.59	2.07	2.59	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	11.95	6.64	1.99	1.33	2.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	16.67	8.72	1.54	2.31	2.57	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	22.24	7.16	2.81	1.53	0.77	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	13.63	4.54	3.03	3.03	1.51	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	19.49	12.10	1.34	0.34	0.67	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	21.01	17.15	4.11	0.24	2.90	0.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	25.85	20.05	3.12	0.89	1.34	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	24.39	12.68	6.34	1.46	2.93	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	19.25	18.34	3.36	1.22	2.44	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	104.10	45.55	9.76	3.25	3.25	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	24.49	22.84	8.27	0.33	1.65	2.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	12.59	4.93	4.93	1.64	1.64	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	11.94	9.05	1.81	2.17	1.81	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	7.12	8.54	1.78	1.42	2.14	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	23.87	3.58	2.39	1.19	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	30.61	14.36	3.11	2.71	1.90	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	13.47	6.47	0.81	0.54	0.54	0.00
immature langerhans cells, donor1	11904-125F5	73.61	48.91	4.36	1.70	1.45	0.73
immature langerhans cells, donor2	11905-125F6	34.85	11.88	0.79	0.79	0.79	0.00
insula, adult, pool1	10039-101F3	48.93	16.75	5.87	11.83	3.12	0.95
keratoacanthoma cell line:HKA-1	10791-110H8	9.43	4.23	0.65	0.65	0.33	0.33
kidney, adult, pool1	10017-101C8	52.07	18.82	4.71	3.30	1.30	1.20
kidney, fetal, pool1	10045-101F9	39.12	17.19	3.68	2.41	0.64	0.85
large cell lung carcinoma cell line:IA-LM	10509-107D5	27.27	39.06	3.83	3.83	1.99	0.57
large cell lung carcinoma cell line:NCI-H460	10839-111E2	36.22	14.10	1.94	0.28	1.24	1.52
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	31.93	16.15	3.30	0.55	2.02	2.20
left atrium, adult, donor1	10079-102A7	5.45	1.09	0.54	1.09	1.09	0.54
left ventricle, adult, donor1	10078-102A6	8.60	4.55	1.01	1.01	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	41.32	15.87	1.64	5.47	0.55	0.82
leiomyoma cell line:10964C	10569-108B2	10.78	3.95	0.36	2.51	0.36	0.36
leiomyoma cell line:15242A	10570-108B3	10.87	6.52	0.54	2.17	1.09	1.09
leiomyoma cell line:15425	10571-108B4	10.93	7.28	0.97	4.37	0.73	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	44.45	12.70	6.35	0.00	0.00	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	15.68	14.64	2.09	1.05	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	34.00	13.58	1.89	0.47	0.71	0.83
liposarcoma cell line:KMLS-1	10782-110G8	8.75	7.97	1.56	2.19	0.94	0.16
liposarcoma cell line:SW 872	10726-110A6	28.51	33.63	3.53	4.02	3.05	0.49
liver, adult, pool1	10018-101C9	216.51	50.08	6.32	2.92	2.27	0.49
liver, fetal, pool1	10086-102B5	45.15	10.35	1.88	2.82	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	24.35	9.33	2.77	2.77	1.75	0.29
locus coeruleus, adult, donor10252	10165-103B3	41.89	15.13	3.69	1.66	1.48	0.18
locus coeruleus, adult, donor10258	10375-105G6	15.24	8.46	2.54	3.39	2.82	0.85
locus coeruleus, newborn, donor10223	10362-105F2	32.81	6.73	3.36	0.42	0.00	0.84
lung adenocarcinoma cell line:A549	10499-107C4	141.16	21.45	3.74	1.94	0.97	8.30
lung adenocarcinoma cell line:PC-14	10408-106B3	8.27	8.27	2.07	2.76	1.38	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	31.11	39.54	4.88	1.85	5.14	0.92
lung, adult, pool1	10019-101D1	23.15	9.92	2.01	1.77	1.42	0.47
lung, fetal, donor1	10068-101I5	13.70	12.56	5.14	1.71	0.00	0.29
lung, right lower lobe, adult, donor1	10075-102A3	13.75	7.79	3.21	2.75	0.00	0.00
lymph node, adult, donor1	10077-102A5	17.51	6.15	1.89	2.37	0.47	1.42
lymphangiectasia cell line:DS-1	10727-110A7	64.00	58.74	5.48	5.26	4.82	1.10
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	146.85	56.14	7.70	3.02	4.38	3.32
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	49.27	38.23	2.55	0.85	0.85	0.85
mature adipocyte, donor1	12231-129F8	9.32	6.66	0.44	1.33	0.00	0.44
mature adipocyte, donor2	12232-129F9	11.21	6.02	2.28	1.25	0.21	0.21
mature adipocyte, donor3	12233-129G1	7.59	4.74	0.71	0.47	0.47	0.00
mature adipocyte, donor4	12234-129G2	7.11	3.95	1.58	2.63	0.53	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	277.10	122.23	17.87	3.57	6.43	8.58
medial frontal gyrus - adult, donor10196	10170-103B8	25.94	15.79	4.51	4.51	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	31.26	11.95	2.76	3.49	1.47	0.92
medial frontal gyrus, adult, donor10258	10368-105F8	19.06	8.58	5.08	5.40	1.59	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	43.08	15.78	4.69	2.56	0.85	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	24.47	12.99	4.39	3.88	2.03	1.01
medial temporal gyrus, adult, donor10252	10156-103A3	36.71	12.52	4.24	2.33	1.70	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	13.48	9.63	13.48	9.63	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	143.54	28.71	14.35	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	19.38	12.92	2.15	3.23	0.00	1.08
medulla oblongata - adult, donor10196	10174-103C3	14.93	8.44	2.60	3.24	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	37.31	14.55	2.32	2.79	0.46	0.46
medulla oblongata, adult, pool1	10038-101F2	40.08	15.02	3.75	3.43	1.63	0.49
medulla oblongata, newborn, donor10223	10361-105F1	23.61	10.42	0.69	1.04	0.35	0.69
medulloblastoma cell line:D283 Med	10838-111E1	24.58	23.25	3.32	0.22	1.11	2.21
medulloblastoma cell line:ONS-76	10759-110E3	19.07	17.49	1.96	0.49	0.61	0.49
melanoma cell line:COLO 679	10514-107E1	25.73	15.09	2.16	0.72	1.29	1.15
melanoma cell line:G-361	10465-106H6	21.99	12.22	3.53	1.09	1.90	0.54
meningioma cell line:HKBMM	10691-109F7	17.73	13.21	1.81	1.09	0.54	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	28.20	17.62	3.52	0.88	0.00	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	28.51	38.88	3.11	1.04	1.81	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	33.30	13.35	1.53	3.53	1.07	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	75.98	10.54	3.27	3.64	0.55	1.64
mesenchymal precursor cell - adipose, donor3	11749-123G3	12.01	4.56	0.83	3.31	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	12.08	7.16	0.84	2.11	0.28	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	13.86	3.27	0.58	1.93	0.19	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	8.33	6.94	0.00	2.08	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	232.74	28.32	2.92	5.84	0.69	12.87
mesenchymal precursor cell - cardiac, donor2	11753-123G7	16.45	6.67	1.04	1.04	0.35	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	40.85	20.43	2.52	3.85	2.12	0.93
mesenchymal precursor cell - cardiac, donor4	11755-123G9	47.40	22.01	2.84	4.73	1.49	0.81
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	57.47	19.35	1.28	3.70	0.85	0.71
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	105.39	21.41	3.95	1.65	1.32	5.60
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	35.84	18.40	1.94	5.12	0.55	0.69
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	18.85	9.77	1.40	2.09	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	22.46	9.60	2.25	2.86	0.82	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	48.89	12.58	2.88	2.52	0.72	2.16
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	15.52	8.90	1.86	3.31	0.83	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	15.73	6.84	1.37	2.96	0.46	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	26.43	10.07	2.10	2.10	0.42	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	24.81	14.79	1.79	2.99	0.60	0.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	70.02	19.69	3.85	3.94	1.05	1.93
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	35.34	8.10	5.52	1.84	1.84	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	17.46	10.30	2.00	2.58	0.29	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	20.63	10.10	2.53	1.26	0.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	15.07	5.48	0.46	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	12.53	5.63	1.28	1.28	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	17.80	4.45	1.57	1.83	0.26	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	10.47	4.93	0.92	0.62	0.31	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	10.59	4.47	1.65	0.94	0.47	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	14.89	4.40	2.03	2.03	1.02	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	12.97	6.68	0.39	2.36	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	19.00	3.24	1.39	0.46	0.93	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	19.32	8.08	1.44	2.02	0.29	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	11.16	5.35	1.12	0.67	1.12	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	15.38	6.01	1.20	1.92	0.72	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	16.13	5.13	2.93	0.00	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	11.41	4.03	0.67	1.01	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	12.69	1.64	0.82	0.82	0.82	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	13.75	6.44	3.44	0.86	1.29	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	8.20	8.20	0.00	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	5.16	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	15.26	5.52	1.95	2.27	0.65	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	14.55	8.73	0.00	0.00	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	9.60	6.93	1.60	2.67	0.53	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	11.45	5.72	0.82	0.82	0.82	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	10.11	8.55	1.94	0.78	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	6.30	10.49	0.00	0.00	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	11.92	3.97	0.00	0.99	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	8.30	5.34	1.78	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	14.62	7.31	3.66	0.00	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	9.50	3.17	1.27	1.90	0.63	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	10.00	4.14	1.03	0.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	8.60	8.60	0.00	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	3.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	10.33	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	7.74	4.89	1.63	0.81	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	8.74	8.74	0.79	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	7.66	6.48	0.59	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	5.30	7.48	1.87	0.94	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	12.03	8.02	0.00	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	18.92	13.01	1.18	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	17.98	5.14	2.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	17.21	6.88	2.75	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	14.84	7.42	0.99	1.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	3.36	11.22	2.24	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	12.72	9.54	1.27	2.54	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	7.66	4.03	0.00	0.00	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	4.36	8.72	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	11.40	5.07	1.27	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	97.10	13.96	4.25	3.03	0.00	5.46
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	103.94	13.56	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	86.49	6.59	1.65	1.65	0.00	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	11.91	5.75	0.40	0.40	0.20	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	14.28	2.60	0.97	0.97	0.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	9.17	9.17	4.07	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	35.59	15.47	3.09	1.55	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	16.06	30.24	3.31	0.47	2.60	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	78.77	73.90	6.02	3.01	5.79	1.62
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	4.27	4.27	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	16.34	10.48	1.03	0.51	0.51	0.10
mesothelioma cell line:Mero-25	10850-111F4	68.77	23.83	4.54	0.91	2.27	3.40
mesothelioma cell line:Mero-41	10851-111F5	35.94	20.54	2.44	0.24	1.47	0.73
mesothelioma cell line:Mero-48a	10852-111F6	21.48	13.95	1.55	1.77	1.11	0.22
mesothelioma cell line:Mero-82	10853-111F7	11.04	7.62	0.79	0.26	0.53	0.53
mesothelioma cell line:Mero-83	10854-111F8	13.45	14.64	2.21	0.34	0.51	0.17
mesothelioma cell line:Mero-84	10855-111F9	25.53	13.40	2.02	0.51	1.01	0.25
mesothelioma cell line:Mero-95	10856-111G1	25.26	12.01	3.52	2.28	0.62	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	27.50	21.20	3.64	2.48	1.49	0.66
mesothelioma cell line:NCI-H226	10846-111E9	23.53	11.58	2.53	0.72	1.27	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	19.82	9.40	3.93	2.56	0.85	0.51
mesothelioma cell line:NCI-H28	10845-111E8	4.83	6.87	1.78	0.51	0.00	0.00
mesothelioma cell line:No36	10857-111G2	15.01	17.61	1.96	0.33	1.30	0.98
mesothelioma cell line:ONE58	10858-111G3	9.75	10.30	1.08	1.90	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	63.53	26.10	7.48	4.03	1.34	0.77
migratory langerhans cells, donor2	11902-125F3	44.94	35.05	4.27	6.11	2.69	0.98
migratory langerhans cells, donor3	11903-125F4	51.15	32.31	6.64	5.56	3.59	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	38.52	33.30	3.59	0.00	2.94	2.29
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	14.20	8.48	1.27	0.64	0.42	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	59.66	27.18	5.76	2.76	2.30	2.30
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	10.66	11.80	1.33	2.66	0.57	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	42.87	15.89	2.77	1.11	0.92	0.92
myeloma cell line:PCM6	10474-106I6	67.80	32.62	7.12	5.73	2.97	2.97
myxofibrosarcoma cell line:MFH-ino	10600-108E6	9.64	9.64	0.51	0.00	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	16.08	6.86	0.78	0.00	0.39	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	58.83	38.00	2.45	0.89	3.90	3.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	65.23	34.34	3.24	1.40	3.60	2.72
nasal epithelial cells, donor2	12227-129F4	46.92	28.70	1.66	1.10	0.00	3.31
neuroblastoma cell line:CHP-134	10508-107D4	69.48	32.21	2.99	0.69	1.15	6.67
neuroblastoma cell line:NB-1	10539-107G8	79.14	29.00	4.30	3.18	1.50	3.74
neuroblastoma cell line:NBsusSR	10607-108F4	171.87	93.63	12.44	1.27	0.63	8.44
neuroblastoma cell line:NH-12	10555-107I6	49.94	23.29	4.85	0.93	2.61	1.12
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	13.76	3.08	2.14	0.71	0.24	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	12.83	7.92	0.79	0.32	0.16	0.63
neuroectodermal tumor cell line:TASK1	10774-110F9	40.45	19.72	3.62	0.60	1.41	2.42
neuroepithelioma cell line:SK-N-MC	10728-110A8	19.07	12.08	0.64	0.00	0.64	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	21.03	14.91	1.86	1.60	0.00	0.53
neutrophil PMN, donor1	12133-128D9	29.75	0.00	0.00	0.00	14.87	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	64.60	14.04	3.55	0.68	2.88	3.89
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	33.62	16.81	1.60	2.40	2.40	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	21.16	9.30	1.28	2.24	0.96	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	22.07	9.72	1.58	2.36	0.79	0.26
nucleus accumbens, adult, pool1	10037-101F1	45.28	15.94	5.53	6.28	3.66	0.19
occipital cortex - adult, donor10196	10172-103C1	14.42	16.48	4.12	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	35.42	13.15	3.49	1.88	2.68	0.00
occipital cortex, newborn, donor10223	10355-105E4	23.29	13.47	2.55	3.64	1.09	1.09
occipital lobe, adult, donor1	10076-102A4	24.93	9.97	3.67	5.77	1.31	0.52
occipital lobe, fetal, donor1	10073-102A1	5.15	9.87	2.15	0.86	0.86	0.00
occipital pole, adult, pool1	10036-101E9	34.45	16.00	4.65	6.39	3.31	0.47
olfactory region, adult	10195-103E6	32.67	11.85	3.82	4.78	0.76	0.96
optic nerve, donor1	10277-104E7	12.01	12.01	4.00	6.00	2.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	265.06	50.58	8.09	4.21	3.19	8.20
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	21.57	12.50	3.98	0.41	2.89	0.69
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	11.18	6.60	0.85	0.34	0.17	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	5.54	3.23	0.46	0.46	0.46	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	28.51	8.53	1.47	2.65	1.47	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	65.40	52.32	9.34	0.93	1.87	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	205.91	33.72	5.51	1.27	0.42	4.67
ovary, adult, pool1	10020-101D2	16.60	12.49	2.53	2.27	0.52	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	17.78	21.63	2.38	0.73	1.65	0.92
pancreas, adult, donor1	10049-101G4	209.76	25.40	5.64	2.82	0.00	6.58
pancreatic carcinoma cell line:NOR-P1	10698-109G5	31.59	27.95	3.07	0.84	1.68	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	36.29	27.94	3.58	2.04	1.36	2.21
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	20.86	14.24	2.15	2.32	2.32	0.17
paracentral gyrus, adult, pool1	10035-101E8	40.18	15.92	5.03	9.15	2.47	0.64
parietal cortex, adult, donor10258	10373-105G4	16.15	8.81	5.87	3.67	1.47	0.00
parietal lobe - adult, donor10196	10171-103B9	15.05	11.29	6.58	4.70	1.88	0.00
parietal lobe, adult, donor10252	10157-103A4	35.91	12.54	3.42	2.85	2.00	1.14
parietal lobe, adult, pool1	10034-101E7	43.80	15.24	5.46	7.31	3.17	0.97
parietal lobe, fetal, donor1	10072-101I9	1.94	12.61	2.91	0.97	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	22.43	16.08	3.74	2.24	0.37	0.37
parotid gland, adult	10199-103F1	155.40	30.83	8.02	4.32	1.85	2.47
penis, adult	10200-103F2	13.43	5.37	2.15	1.07	0.54	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	30.87	13.39	2.23	0.56	0.19	0.93
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	44.00	19.38	3.35	2.62	1.75	2.62
pineal gland - adult, donor10196	10179-103C8	22.58	18.06	5.81	4.52	1.94	0.00
pineal gland, adult, donor10252	10160-103A7	19.54	31.39	4.15	2.37	3.55	0.00
pineal gland, adult, donor10258	10377-105G8	13.80	20.69	6.27	1.88	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	64.76	28.33	9.11	9.11	2.02	0.00
pituitary gland, adult, donor10252	10162-103A9	65.15	42.22	5.73	6.78	4.17	0.52
pituitary gland, adult, donor10258	10378-105G9	28.94	18.73	7.66	6.81	1.70	1.70
placenta, adult, pool1	10021-101D3	30.42	20.32	5.81	2.04	1.51	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	30.19	17.88	1.72	0.53	1.19	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	26.15	11.98	2.65	1.56	0.16	0.00
pons, adult, pool1	10033-101E6	41.74	14.80	4.48	3.87	2.07	0.34
postcentral gyrus, adult, pool1	10032-101E5	44.20	18.83	5.14	7.24	2.96	0.96
promyelocytes/myelocytes PMC, donor1	12132-128D8	282.34	54.38	10.46	14.64	0.00	12.55
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	11.02	11.02	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	93.89	11.74	11.74	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	30.88	29.72	4.95	1.89	3.35	0.29
prostate cancer cell line:PC-3	10439-106E7	46.10	21.42	2.72	5.26	1.45	1.27
prostate, adult, pool1	10022-101D4	16.05	10.97	3.08	2.09	1.18	0.36
putamen, adult, donor10196	10176-103C5	56.66	13.93	4.72	4.72	2.12	0.94
putamen, adult, donor10252	10152-102I8	52.94	23.53	1.96	1.96	5.88	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	9.84	5.46	7.65	3.28	2.19	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	23.44	8.70	4.83	1.69	2.17	0.24
putamen, newborn, donor10223	10365-105F5	17.99	6.00	0.75	0.75	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	112.88	44.80	6.98	2.62	2.04	3.78
rectum, fetal, donor1	10067-101I4	15.30	1.39	1.39	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	29.47	19.29	3.39	1.06	2.97	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	7.04	11.60	1.24	0.83	1.66	0.00
retina, adult, pool1	10030-101E3	21.07	12.82	3.38	3.28	1.69	0.20
retinoblastoma cell line:Y79	10475-106I7	26.24	14.03	3.90	1.30	2.08	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	22.13	17.34	5.41	2.34	2.09	0.37
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	26.43	30.65	4.50	0.84	1.41	1.41
sacrococcigeal teratoma cell line:HTST	10695-109G2	10.61	5.30	0.00	3.79	0.76	0.76
salivary acinar cells, donor1	11771-123I7	9.71	7.93	1.46	2.43	1.13	0.49
salivary acinar cells, donor2	11772-123I8	7.71	4.54	0.96	1.38	0.69	0.00
salivary acinar cells, donor3	11773-123I9	8.61	4.63	3.97	1.32	0.66	0.00
salivary gland, adult, pool1	10093-102C3	52.62	25.74	10.30	2.29	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	17.45	7.84	1.60	0.84	0.67	0.76
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	15.75	6.82	1.29	1.53	0.47	1.18
seminal vesicle, adult	10201-103F3	35.45	14.28	5.29	3.17	1.59	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	76.76	31.34	4.86	3.89	0.73	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	17.11	11.83	2.52	0.75	1.51	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	16.06	19.07	0.00	0.00	5.02	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	41.51	17.46	1.88	0.13	0.67	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	79.14	28.74	3.87	2.43	1.22	2.98
signet ring carcinoma cell line:NUGC-4	10483-107A6	17.93	8.77	1.42	0.26	0.39	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	7.80	1.42	0.00	0.71	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	11.87	3.24	1.68	0.96	0.48	0.24
skeletal muscle, fetal, donor1	10066-101I3	2.01	3.02	3.02	1.01	1.01	0.00
skin, adult, donor1	10074-102A2	0.00	6.79	13.57	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	18.31	5.68	1.89	1.89	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	24.35	29.35	2.67	3.67	3.34	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	20.49	24.90	2.21	1.26	1.89	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	24.48	23.13	5.78	0.58	1.93	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	41.21	24.23	2.31	1.48	2.80	1.98
small cell lung carcinoma cell line:NCI-H82	10842-111E5	28.79	23.32	4.34	0.00	0.97	0.64
small cell lung carcinoma cell line:WA-hT	10562-108A4	156.25	145.13	18.52	6.54	5.88	4.36
small intestine, adult, pool1	10024-101D6	43.36	12.78	3.11	2.39	1.19	0.72
small intestine, fetal, donor1	10064-101I1	15.48	8.35	2.70	1.97	1.72	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	117.97	44.11	3.59	2.56	0.51	3.59
smooth muscle, adult, pool1	10048-101G3	13.44	4.65	1.29	0.78	0.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	144.20	25.46	5.63	1.61	1.34	10.99
spinal cord - adult, donor10196	10181-103D1	13.76	6.19	1.61	1.84	2.75	0.46
spinal cord, adult, donor10252	10159-103A6	16.17	14.19	3.55	3.15	0.79	0.00
spinal cord, adult, donor10258	10369-105F9	15.22	4.15	4.84	1.38	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	19.51	13.42	1.83	3.66	2.44	0.61
spinal cord, newborn, donor10223	10359-105E8	45.00	13.78	2.30	2.30	1.38	2.76
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	34.35	9.56	2.24	2.54	1.05	1.49
spleen, adult, pool1	10025-101D7	28.08	14.87	2.75	1.76	0.88	0.22
spleen, fetal, pool1	10044-101F8	32.10	11.84	2.30	1.27	0.95	0.40
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	29.19	25.15	2.38	1.35	1.24	0.62
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	20.32	8.92	1.14	0.38	1.14	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	61.50	27.61	9.44	4.19	2.10	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	31.27	15.64	1.17	1.56	1.95	2.35
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	51.10	20.04	2.14	1.01	1.58	3.26
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	21.60	27.96	2.97	1.27	1.69	2.54
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	34.27	27.50	2.12	2.96	0.85	0.00
stomach, fetal, donor1	10062-101H8	26.70	8.54	5.34	4.27	1.07	2.14
submaxillary gland, adult	10202-103F4	33.04	16.52	4.56	7.41	1.14	0.57
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	54.27	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	33.03	12.25	2.91	1.04	0.62	0.42
substantia nigra, adult, donor10258	10371-105G2	22.76	5.17	7.24	2.59	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	11.31	6.36	0.71	0.00	1.41	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	27.74	17.19	2.29	1.15	2.06	1.83
temporal lobe, adult, pool1	10031-101E4	43.32	15.34	5.09	7.80	3.65	0.42
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	6.41	9.26	2.14	0.71	1.42	2.14
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	8.79	9.67	3.08	1.76	0.44	0.88
tenocyte, donor1	11763-123H8	12.22	5.24	1.05	1.40	0.70	0.35
tenocyte, donor2	11765-123I1	6.87	2.29	1.14	2.67	0.00	0.38
tenocyte, donor3	11768-123I4	6.67	1.85	0.74	1.85	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	20.91	25.32	2.55	0.34	2.21	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	11.87	22.35	1.23	0.31	1.23	0.15
teratocarcinoma cell line:PA-1	10807-111A6	26.81	19.53	4.03	1.24	1.86	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	126.31	36.18	3.68	1.90	1.52	4.70
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	70.34	60.51	9.45	0.76	3.78	3.78
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	67.95	36.97	4.80	1.20	1.31	3.16
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	37.46	21.50	4.56	0.65	2.93	0.65
testis, adult, pool1	10026-101D8	24.16	19.54	3.76	14.71	2.90	0.54
testis, adult, pool2	10096-102C6	31.12	27.52	9.02	29.32	6.77	1.35
thalamus - adult, donor10196	10168-103B6	20.98	6.62	1.10	2.21	2.21	0.00
thalamus, adult, donor10252	10154-103A1	37.82	12.35	3.13	2.03	0.94	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	12.32	6.16	3.08	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	10.21	3.79	2.64	1.81	0.33	0.33
thalamus, newborn, donor10223	10366-105F6	23.59	9.78	3.45	2.30	0.00	0.00
throat, adult	10209-103G2	18.97	9.49	3.50	1.50	0.50	0.00
throat, fetal, donor1	10061-101H7	17.67	7.01	2.44	4.27	0.91	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	29.61	20.87	2.78	2.19	1.59	1.39
thymus, adult, pool1	10027-101D9	34.99	18.29	2.09	0.89	1.29	0.99
thymus, fetal, pool1	10043-101F7	22.03	11.95	1.25	0.21	0.94	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	41.75	13.30	2.26	1.06	1.33	1.46
thyroid carcinoma cell line:TCO-1	10783-110G9	78.93	27.10	6.29	3.35	2.65	2.10
thyroid, adult, pool1	10028-101E1	135.30	49.64	12.88	7.74	2.52	1.49
thyroid, fetal, donor1	10060-101H6	67.50	28.74	8.44	7.91	2.11	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	9.24	3.08	0.00	3.08	3.08	0.00
tongue, adult	10203-103F5	10.23	4.88	1.40	0.23	0.23	0.23
tongue, fetal, donor1	10059-101H5	6.70	4.34	0.79	0.79	0.39	0.00
tonsil, adult, pool1	10047-101G2	35.06	13.92	3.71	2.00	1.10	0.30
trachea, adult, pool1	10029-101E2	48.83	24.38	4.50	3.76	0.98	0.74
trachea, fetal, donor1	10058-101H4	27.31	7.69	3.46	5.00	0.77	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	20.90	15.59	1.42	0.71	1.77	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	91.89	30.60	3.34	1.72	2.23	1.62
transitional-cell carcinoma cell line:JMSU1	10492-107B6	153.87	47.48	6.58	3.60	2.66	5.64
tridermal teratoma cell line:HGRT	10694-109G1	24.73	22.83	0.00	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	45.12	16.17	2.37	5.16	1.27	1.52
umbilical cord, fetal, donor1	10057-101H3	18.78	10.43	2.09	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	16.21	12.11	6.14	2.39	0.85	0.00
uterus, fetal, donor1	10055-101H1	20.48	4.61	2.56	1.02	0.00	0.00
vagina, adult	10204-103F6	25.20	20.03	3.23	1.29	1.94	0.00
vein, adult	10191-103E2	14.91	5.70	1.97	1.53	0.66	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	20.29	13.35	3.74	0.27	2.14	0.27